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Sigma Receptors Modulation of Voltage-gated Ion
Channels in Rat Autonomic Neurons
Hongling Zhang

ABSTRACT

Sigma receptors have been implicated in the regulation of the
cardiovascular system. Some of the cardiovascular effects of sigma receptors
may be through the modulation of autonomic neurons. Studies on the
expression and cellular function of sigma receptors in autonomic neurons were
conducted in neonatal rat intracardiac (ICG) and superior cervical ganglia (SCG).
Individual neurons from SCG and ICG were shown to express transcripts
encoding the sigma-1 receptor. The effects of sigma receptors activation on
high-voltage-activated Ca2+ channels was studied in isolated neurons of these
ganglia. Bath application of sigma receptor agonists depressed peak calcium
channel currents in a dose-dependent manner and the rank order potency of
haloperidol> ibogaine > (+)-pentazocine > DTG is consistent with the effects
being mediated by a sigma-2 receptor. Sigma receptor antagonist, metaphit,
blocked DTG-mediated inhibition of Ca2+ current. Sigma ligands also altered the
biophysical properties of these channels.

viii

Activation of sigma receptors reversibly blocked delayed outwardly
rectifying potassium channels, large conductance Ca2+-sensitive K+ channels,
and the M-current with maximal inhibition >80%. The rank order potency of
different sigma ligands suggests that the effect is mediated by sigma-1 receptor.
While bath application of sigma ligands depolarized ICG neurons, the number of
action potentials (AP) fired by the cells in response to depolarizing current pulses
was decreased. Experiments on the signal transduction cascade mediated the
inhibition of K+ and Ca2+ channels by sigma ligands showed that the signal
transduction pathway does not involve a diffusible cytosolic second messenger
or a G-protein.
Sigma ligands also modulate voltage-gated Na+ channels (VGSC) in ICG
neurons. Bath application of sigma ligands inhibited VGSC current with maximal
inhibition >90% and altered the biophysical properties of VGSC. The latency of
AP generation during depolarizing current ramp was increased by sigma ligands
and this effect is through the inhibition of VGSC.
These data suggest that activation of sigma receptors on autonomic
neurons modulates voltage-gated Ca2+, K+ and Na+ channels and as a result, the
generation of AP is inhibited in these neurons. Sigma receptors are likely altering
the cell-to-cell signaling in autonomic ganglia and thus regulating cardiac function
by the peripheral nervous system.
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CHAPTER 1
BACKGROUND AND SIGNIFICANCE

SIGMA RECEPTORS
Sigma receptors were postulated in 1976 by Martin et al based upon the
actions of the benzomorphan opiate SKF-10,047 and were originally thought to
be a type of opiate receptor (Martin et al., 1976). Two subsequent findings
convincingly demonstrated that sigma receptors are not members of the opiate
receptor family. First, the enantioselectivity for the ligands is different: opiate
receptors are selective for the (-) isomers of opium-derived narcotics, narcotic
antagonists, and their congeners. Sigma receptors are enantioselective for the
(+) isomers. Second, traditional opiate receptors antagonists such as naloxone
or naltrexone are ineffective against both the in vivo and the in vitro effects of
sigma ligands (Brady et al., 1982; Iwamoto, 1981; Katz et al., 1985; Slifer and
Balster, 1983; vaupel, 1983). Therefore, the sites defined as sigma today are not
opioid and represent a unique type of receptor.
Given that SKF10,047 and phencyclidine (PCP) produce many of the
same psychotomimetic effects, some investigators proposed a common receptor
for the two, called the sigma/PCP site (Zukin et al., 1984). Further analysis later
1

revealed that the two sites are separate and show different localization across
brain area. The sigma site has high affinity for SKF10,047, lower affinity for PCP,
and is also sensitive to low concentrations of haloperidol. In contrast, the PCP
site has high affinity for PCP, lower affinity for SKF10,047, and is insensitive to
low concentration of haloperidol. It is now well established that the sigma site
represent a unique binding site in mammalian brain and peripheral organs,
distinct from any other known transmitter receptors (Walker et al., 1990).
At least two subtypes of sigma receptor have been classified based on the
findings from biochemical and radioligand binding experiments and have been
designated as sigma-1 and sigma-2. The sigma-1 site was suggested for the
guinea pig brain traditional sigma while sigma-2 was rat pheochromocytoma
(PC12) cell sigma-like sites, respectively (Hellewell and Bowen, 1990; Quirion et
al., 1992). Only sigma-1 receptor has been cloned and in human, sigma-1 gene
is located on chromosome 9p13, a region associated with psychiatric disorders
(Prasad et al., 1998). The structure of the sigma-1 receptors showed no
homology with other known mammalian protein, but possessed some homology
with fungal sterol isomerases (Hanner et al., 1996; Kekuda et al., 1996; Seth et
al., 1998). The cDNA of sigma-1 receptor predicted a protein of 223 amino acids
and the molecular weight is 25 KDa. Initial hydropathy analysis of the deduced
amino acid sequence of sigma-1 receptor suggested a single putative
transmembrane domain, which played a critical role in ligand binding of this
receptor (Prasad., 1998; Yamamoto et al., 1999). Subsequently, when
2

expressed in Xenopus lavis oocytes, the domain accessibility experiments
suggested that sigma-1 receptor has two membrane-spanning segments, with
the NH2 and COOH termini on the cytopalsmic side of the membrane (Aydar et
al., 2002). In this model, the proposed ligand binding domain is located in the
COOH-terminus intracellular portion.
In the oocyte, guinea pig sigma-1 receptor was found mainly in the plasma
membrane (Aydar et al., 2002), however, it has been found that at N-terminus,
there was an endoplasmic reticulum retention signal motif, suggests that sigma-1
receptor exists not only in the plasma membrane but also in intracellular
membranes, which makes it different from conventional neurotransmitter
receptors (Kekuda et al., 1996; Hanner et al., 1996).
The molecular nature of sigma-2 receptor is still unknown and it has been
presumed that sigma-2 receptor gene encodes a protein of Mr 21,500. In both
mice and humans, it has been suggested that the splicing variants of the sigma-1
receptor gene could display sigma-2 receptor binding activities (Monassier and
Bousquet, 2002). However, in the sigma-1 receptor knockout mouse, sigma-2
receptor binding sites have no changes compared with the wild type mouse,
suggesting that sigma-1 and sigma-2 are not two isoforms of the same protein
(Langa et al., 2003). Similar to sigma-1 receptor, some studies also showed that
sigma-2 receptors are intracellular receptors located in the membranes of the
endoplasmic reticulum and mitochondria (Bowen 2000).

3

Sigma-1 and sigma-2 receptor exhibits a distinct pharmacological profile.
Sigma-1 receptors display high affinity for (+)-pentazocine, (+)-SKF-10,047 and
other (+)-benzomorphans, whereas sigma-2 receptors have low affinity for these
compounds but have high affinity for ibogaine (Hellewell and Bowen, 1990;
Hellewell et al., 1994; Bowen et al., 1995).
Since originally proposed, sigma receptors have been observed across
many species and are present at high levels in CNS, immune system, liver and
kidney. (Wolfe and De Souza, 1992; Hellewell et al., 1994) Although the
function of these receptors is not well understood, sigma receptors have been
implicated in the modulation of various biochemical, behavior and physiological
processes (Walker et al., 1990). In the central nervous systems, sigma receptors
are concentrated in brainstem areas that regulate motor function, limbic
structures, some predominantly sensor areas and areas associated with
endocrine function. Sigma receptors have been implicated not only in the
regulation of posture and motor activity (Glodstein et al., 1989, Bowen et al.,
1988), but also in the modulation of opioid analgesia (King et al., 1997), cocaineinduced toxicity (McCracken et al., 1999), learning and memory (Maurice et al.,
1998), drug abuse (Maurice et al., 2003), neuroprotection in cerebral ischemia
(Takahashi et al., 1996; Lockhart et al., 1995; Goyagi et al., 2001), as well as in
regulation of neurotransmitter release and modulation of neurotransmitter
receptor function (Matsuno et al., 1993; Couture and Debonnel, 1998; Patrik et
al., 1993).
4

It was also found that both subtypes of sigma receptors are expressed in
very high density in tumor cell lines derived from various tissues, which suggests
important cellular functions of sigma receptors in cancer and potential diagnostic
utility for tumor imaging agents which target sigma binding sites (Vilner et al.,
1995; Brent and Pang 1995; Barbieri et al., 2003). Thus, it is likely that sigma
receptors have important functions outside of the nervous system and may serve
a more general role than a neurotransmitter receptor.
Although there is evidence for the existence of sigma receptor binding
sites in brain and tissue extracts, no endogenous functional ligand for sigma
receptors has been conclusively identified. Various candidates have been
suggested, such as, progesterone (Su et al., 1988), Neuropeptide Y (NPY),
peptide YY (Roman et al., 1989) and zinc (Connor and Chavkin, 1992). These
data suggest that sigma-binding sites constitute a true receptor that binds to
endogenous ligands released in response to neurostimulation.

SIGMA RECEPTORS IN CARDIOVASCULAR SYSTEM
Much of the initial interest in sigma receptors was driven by their potential
role in the actions of antipsychotic drug. This was due mainly to their high affinity
for most of the typical neuroleptics, such as haloperidol and their shared affinity
for compounds known to cause psychotomimetic activity such as Nallylnormetazocine (SKF10,047) (Su, 1982; Tam and Cook, 1984). Sigma
receptors are also found in high density in many tissues outside of the central
5

nervous system, such as, endocrine, immune, and gastric system (see Walker et
al., 1990). Sigma binding sites have been detected in cardiac myocytes from
neonatal and adult rats (Ela et al., 1994; Novakova et al., 1995). In neonatal rat
cardiac myocytes, sigma receptor ligands, at nanomolar concentrations, exert a
complex effect on the amplitudes and frequencies of contraction, Ca2+ fluxes and
[Ca2+]I transients (Ela et al., 1994). Pretreatment of these cells with sigma
ligands caused the desensitization of the receptor (Ela et al., 1996). However,
sigma ligands, at concentrations of 10 nM and higher, markedly increased the
amplitude of systolic cell contraction and the amplitudes of [Ca2+]I transients in
adult rat cardiac myocytes (Novakova et al., 1995). These effects were shown to
be mediated by elevated production of inositol 1,4,5-trisphosphate (IP3) and
potentiation of the systolic release of Ca2+ from sarcoplasmic reticulum-Ca2+
stores.
It has been shown that sigma receptor antagonist DuP 734 increase the
heart tolerance to ischemic and reperfusion arrhythmias both in vivo and in vitro
(Lishmanov et al., 2000a). Conversely, the sigma receptor agonists (+)-SKF10,047, 1,3-di-O-tolyguanidin (DTG), and (+)-3-[3-hydroxyphenyl]-N-(1propyl)piperidine have been shown to produce tachycardia by activating central
and peripheral sigma receptors (Wu and Martin, 1989; Lishmanov et al., 2000b).
Clinical study has also been shown that some psychiatric patients during therapy
with haloperidol, which is deemed as sigma-1 receptor antagonist and sigma-2
receptor agonist, tend to have cardiac side effects such as arrhythmia,
6

tachycardia and sudden cardiac death (Settle and Ayd, 1983; Mehta, 1979;
Turbott et al., 1984). While the effects of sigma ligands in cardiac muscle may
be involved in the cardiovascular effects of these agents, very little is known
about sigma receptors in autonomic neurons that innervate the heart and
regulate cardiovascular function.

SIGMA RECEPTORS IN AUTONOMIC NEURONS
Some evidence does exist that suggests that sigma receptors play an
important role in the function of peripheral neurons. For example, sigma
receptors have been shown to block contractions of longitudinal muscle elicited
by both electrical stimulus or by exogenous serotonin in the guinea pig
ileum/myenteric plexus preparation via inhibition of acetylcholine release from
myenteric neurons (Campbell et al., 1989). Conversely, sigma receptors
potentiate neurogenic twitch contraction in the mouse vas deferens by inhibiting
K+ channels in sympathetic neurons for the hypogastric ganglion, which increase
norepinephrine release from these cells (Campbell et al., 1987). Both sigma-1
and sigma-2 receptors have been detected in rat pheochromocytoma (PC12)
which exhibit a phenotype similar to sympathetic neurons and sigma-2 receptors
were shown to enhance amphetamine-stimulated dopamine release from these
cells (Hellewell and Bowen, 1990; Sagi et al., 1996; Weatherspoon and Werling,
1999).

7

SIGMA RECEPTORS MODULATION ON VOLTAGE-GATED ION CHANNELS
The effects of sigma receptor ligands on voltage-gated ion channels have
been investigated in several types of cells, and K+ channels are the most
extensively studied. In frog pituitary melanotrophs, for example, sigma receptors
activation increased electrical activity by inhibiting K+ currents via activation of a
cholera toxin-sensitive G protein; even though sigma receptors share no
homology with classic G-protein coupled receptors (Soriani et al., 1998; Soriani
et al., 1999a). Conversely, in rat neurohypophysial terminals, neither G-protein
nor any soluble cytoplasmic factor were involved in the modulation of K+
channels by pentazocine or (+)SKF10047 (Lupardus et al., 2000). Aydar et al
reconstituted sigma-1 receptor modulation of Kv1.4 and Kv1.5 in oocytes by
heterologous expression of the K+ channels with sigma-1 receptors. It was found
that (+)SKF10047 depressed K+ current only in the oocytes that injected with
both sigma-1 receptors and K+ channel subunits and it was also showed that the
sigma-1 receptor alters the kinetic properties of Kv1.4 channel in the absence of
sigma ligands (Aydar et al.,2002). These findings together with the observation
that sigma-1 receptor forms an immunoprecipitating complex with K+ channels
both in rat neurohypophysis and when coexpressed in oocytes, led investigators
to propose that the sigma receptor functions as a ligand-regulated auxiliary K+
channel subunit (Aydar et al., 2002). These studies have made advances in
deducing the mechanisms of the signal transduction pathway of the ion channel
modulation.
8

Ion channels are expressed in several types of tumor cells and play an
important role in metastasis, an integral aspect of which is the control of cell
growth and proliferation. For example, down-regulation of K+ channel amplitude
has been associated with the metastatic phenotype in human breast and prostate
cancer (Wonderlin and Strobl, 1996; Fraser et al., 2003) and voltage-gated Na+
channels are also involved in the metastatic cascade in prostate cancer (Fraser
et al., 2003). In DMS-114 cells (a tumor cell line derived from human small cell
lung carcinoma), sigma receptors are highly expressed and sigma ligands have
been shown to inhibit voltage-gated K+ channel currents (Wilke et al., 1999).
Because both subtypes of sigma receptors are expressed in very high density in
tumor cell lines (Vilner et al., 1995; Brent and Pang., 1995; Barbieri et al., 2003)
and sigma-1 receptors functions as a auxiliary K+ channel subunit, it raises the
possibility that sigma receptor ligands could be useful as novel anti-cancer
agents (Adyar et al., 2002).

BIOMEDICAL SIGNIFICANCE
It has been suggested that sigma receptors may regulate the
cardiovascular system (Ela et al., 1994) and direct effects of sigma ligands on
cardiac muscle have been documented, very little is known about sigma
receptors in autonomic neurons that innervate the heart. The presence of
putative endogenous ligands of sigma receptors, including neuropeptide Y
(Roman et al., 1989) and substance P (Larson and Sun 1993), in these ganglia
9

(Hassall and Burnstock 1984; Karhula 1995; Kessler and Black 1982; Papka et
al., 1981) suggests that sigma receptors may be activated under physiological
conditions, affecting cell-to-cell signaling in the ganglia, and ultimately the
regulation of cardiac functions by the autonomic nervous system. It is also
known that drugs of abuse, such as cocaine and PCP, have high binding affinity
with sigma receptors, and their cardiovascular side effects may be due to the
activation of sigma receptors in autonomic neurons.
Current studies on the modulation of voltage-gated ion channels by sigma
receptors of autonomic neurons will not only serve to increase our understanding
of the functions of these receptors in the heart but also on the cellular functions
of these poorly understood receptors.
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CHAPTER 2
SIGMA RECEPTORS MODULATION ON HIGH-VOLTAGE-ACTIVATED
CALCIUM CHANNELS IN RAT SYMPATHETIC AND PARASYMPATHETIC
NEURONS

INTRODUCTION

Sigma receptors are widely distributed in mammalian brain and peripheral
systems and organs. These receptors have been pharmacologically defined into
two subclasses of receptors, sigma-1 and sigma-2 (Hellewell and Bowen 1990;
Quirion et al., 1992), with a major difference being the higher affinity of sigma-1
receptors for (+) pentazocine (Quirion et al., 1992) and the greater affinity of
sigma-2 receptors for ibogaine (Bowen et al., 1995). While only the sigma-1
receptor has been cloned, studies using photolabeling techniques with sigma
ligands on guinea pig brain and PC12 cell membranes suggest that distinct
molecular entities exist that correspond to the two sigma receptor subtypes
(Hellewell and Bowen 1990). The function of these receptors is not well
understood; however, sigma receptors have been implicated in the modulation of
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various biochemical, behavioral, and physiological processes (Walker et al.,
1990).
It has been suggested that sigma receptors may regulate the
cardiovascular system (Ela et al., 1994). Sigma ligand binding sites have been
detected in cardiac myocytes, and sigma ligands, including (+)-pentazocine and
haloperidol, have been shown to alter contractility, Ca2+ influx, and contraction
rate in cultured cardiac myocytes (Ela et al., 1994; Novakova et al., 1995).
However, while direct effects of sigma ligands on cardiac muscle have been
documented, very little is known about sigma receptors in autonomic neurons,
and in particular sympathetic or parasympathetic neurons that innervate the
heart.
A process frequently targeted by sigma receptor modulation is intracellular
calcium homeostasis. In the human neuroblastoma cell line, SK-N-SH, sigma-2
receptors have been shown to evoke release of Ca2+ from intracellular stores
(Vilner and Bowen, 2000). Studies have also suggested that sigma ligands may
block Ca2+ channels in hippocampal neurons and vascular smooth muscle
(Church and Fletcher, 1995; Flaim et al., 1985), although these effects were
attributed to direct modulation of Ca2+ channels by the sigma ligands. The effect
of sigma receptor activation on calcium channels, and in particular calcium
channels of autonomic neurons, remains to be elucidated. Regulation of calcium
channel function is a means by which various neurotransmitters exert their effects
on autonomic neurons (Jeong et al., 1999). For example, both neuropeptide Y
12

and norepinephrine depress calcium channel currents in rat ICG neurons (Jeong
et al., 1999; Xu and Adams 1993). This inhibition of calcium channels is believed
to be a mechanism by which the sympathetic nervous system modulates the
activity of the parasympathetic nervous system. Similarly, acetylcholine, acting
via M4 muscarinic receptors, blocks calcium channel currents in intrinsic cardiac
neurons (Cuevas and Adams 1997). This phenomenon is likely to represent a
feedback mechanism in cholinergic parasympathetic neurons.
Experiments were undertaken to determine whether sigma receptors are
present in autonomic neurons of the sympathetic superior cervical ganglion
(SCG) and the parasympathetic intracardiac ganglion (ICG), and whether
activation of these receptors modulates the biophysical properties of calcium
channels in these cells. Results indicate that sigma-1 receptor transcripts are
expressed by individual autonomic neurons. Furthermore, sigma receptors were
shown to depress peak Ca2+ channel currents, increase the rate of Ca2+ channel
inactivation, and shift the voltage dependence of both steady-state inactivation
and activation toward more negative potentials. Pharmacological experiments
suggest that sigma-2 receptors modulate Ca2+ channels in these cells and that
these receptors couple to Ca2+ channels via a signal transduction cascade that
involves neither a diffusible cytosolic second messenger nor a G protein.

13

METHODS

Preparation and Electrical Recording
Modulation of depolarization-activated Ca2+ channels by sigma receptor
activation was studied in isolated neurons of neonatal rat ICG and SCG. The
preparation of cultured neurons of neonatal rats (3-10 day old) and the
electrophysiological recording methods used here have been previously
described (Cuevas and Adams, 1994; Cuevas et al., 2000). For the SCG
preparation, neonatal rats were killed by inhalation of carbon dioxide; whereas for
isolation of ICG neurons, rats were killed by decapitation. All procedures were
done in accordance with the regulations of the Institutional Animal Care and Use
Committee.
Membrane currents in autonomic neurons, cultured for 24-72 h, were
studied under voltage-clamp mode using the whole cell recording configuration of
the patch-clamp technique (Hamill et al., 1981). Electrical access was achieved
through the use of the amphotericin B perforated-patch method (Rae et al., 1991)
to preserve the intracellular integrity of the neurons and prevent calcium current
rundown (Xu and Adams, 1992). For perforated-patch experiments, a stock
solution of amphotericin B (60 mg/ml) in dimethylsulphoxide (DMSO) was
14

prepared and diluted in pipette solution immediately prior to use to yield a final
concentration of 198 µg/ml amphotericin B in 0.33% DMSO. Final patch pipette
resistance was 1.0-1.3 MΩ to permit maximal electrical access under the present
recording configuration. Junction potentials generated by the ions in the pipette
and bath solutions were compensated for via the Pipette Offset control of the
Axopatch 200B. To test for amphotericin B incorporation into the membrane
patch following gigaseal formation, the neurons were held at
voltage pulses to

60 mV, and 20-ms

65 mV were applied at 1 Hz. In successful experiments there

was an increase in a fast capacitive transient, the appearance of a slow
capacitive transient, and a decrease in the series resistance (Rs). To minimize
voltage error produced by Rs, Rs was monitored throughout the experiment, and
only cells in which Rs was consistently 3 MΩ following 50% Rs compensation
were used. Also, to minimize space-clamp artifact, only cells with no large visible
processes were selected for the experiments.
Depolarization-activated Ca2+ channel currents were evoked using voltage
jumps from

90 mV to more positive potentials. Capacitive and leak currents

were subtracted using the P/4 protocol, which assumes a linear relationship for
these currents at voltages less than

60 mV (Xu and Adams, 1992). Membrane

currents were amplified using an Axopatch 200B patch-clamp amplifier (Axon
Instruments, Union City, CA), filtered at 5 kHz ( 3 dB; 4-pole Bessel filter), and
digitized at 20 kHz (Digidata 1200B).
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Ca2+ currents elicited by long (2 s) depolarizations were fit using single or
double exponential functions and the Clampfit 6.0.5 program (Axon Instruments).
Activation and steady-state inactivation kinetics were described using Boltzmann
distributions, and dose-response curves were fit using the Hill equation. Analysis
of these data was conducted using the SigmaPlot 2000 program (SPSS Science,
Chicago, IL). Data points represent means ± SE. Statistical difference was
determined using paired t-test for within-group experiments, and unpaired t-test
for between groups experiments, and was considered significant if P < 0.05.

RT-PCR
RT-PCR techniques, similar to those previously reported (Cuevas et al.
2000), were used for the detection of sigma-1 receptor expression in autonomic
neurons. Total RNA was isolated from ICG ganglia and associated tissue and
from SCG (RNeasy, Qiagen, Hilden, Germany). RNA was reverse-transcribed in
a 20-µl reaction volume using the SuperScript First-Strand Synthesis System for
RT-PCR (Invitrogen, San Diego, CA). As a negative control, a PCR reaction with
only water was conducted to eliminate the possibility of false positives due to
contaminating cDNA. Primers specific for sigma-1 receptor transcripts were
designed to span an intron to discriminate between genomic DNA and cDNA.
The sequences of the primers used were: sigma-1(sense)GTCTTTTGCACGCCTCGCTGTCTGAGTACG, sigma-1(antisense)ACCCTCTCTGGATGGAGGTGAGTGC, which yielded a product size of 639
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base pairs. PCR reactions were conducted using the SuperScript System with
Platinum Taq DNA polymerase (Invitrogen). The cycling parameters were one
cycle of 94°C for 2 min; 30 cycles of 94°C for 30 s, 61°C for 45 s, and 72°C for 1
min; and 1 cycle of 72°C for 5 min.
For single-cell RT-PCR experiments, SCG and ICG neurons were
dissociated, and cytoplasm was extracted from isolated neurons as previously
described (Poth et al., 1997). Briefly, the cellular content of individual neurons
was harvested using the dialyzing whole cell configuration of the patch-clamp
technique. The patch pipettes were filled with 3 µl of 1× SuperScript One-Step
RT-PCR Reaction Mix (Invitrogen) containing 1 U/µl RNAsin (Promega, Madison,
WI). Following extraction of the cytoplasm, the content of the pipette was
expelled into a microfuge tube and quickly frozen on dry ice. Single-cell RT-PCR
experiments were conducted immediately following the extraction using
SuperScript One-Step RT-PCR with Platinum Taq (Invitrogen). Negative controls
for these experiments involved suctioning extracellular solution via a patch pipette
located directly above the cells. These controls were carried through all
subsequent reactions to rule out the possibility of contamination from cytoplasm
from nearby cells or sigma receptor clones isolated in the laboratory. The cycling
parameters were 1 cycle of 50°C for 30 min and 95°C for 2 min; 40 cycles of
94°C for 30 s, 61°C for 45 s, and 72°C for 1 min; and 1 cycle of 72°C for 5 min.
RT-PCR products were gel purified using a QIAEX II Gel Purification kit
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(QIAGEN) and sequenced by the Molecular Biology Core Facility at the H. Lee
Moffitt Cancer Center and Research Institute.

Solutions and Reagents
The bath solution used in these experiments was a physiological saline
solution (PSS) composed of (in mM) 70 NaCl, 70 tetraethylammonium chloride
(TEA), 5 BaCl2, 1.2 MgCl2, 7.7 glucose, 0.0005 tetrodotoxin (TTX), and 10
HEPES (pH to 7.2 with NaOH). Barium was used as the charge carrier to
maximize Ca2+ channel current amplitude, and to minimize any intracellular Ca2+dependent current rundown (Xu and Adams 1992). All drugs, including sigma
ligands, were bath applied at room temperature at a rate of ~2 ml/min into a 0.3ml recording chamber, which permitted rapid exchange of bath solution. The
pipette solution used for perforated-patch experiments contained (in mM) 75
Cs2SO4, 55 CsCl, 5 MgSO4, and 10 HEPES (pH to 7.2 with N-methyl-dglucamine). Block of ionic current through Ca2+ channels was achieved via bath
application of 100 µM CdCl2 (Xu and Adams 1992). For studies using
conventional (dialyzing) whole cell recording configuration, the pipette solution
contained (in mM) 140 CsCl, 2 MgCl2, 2 ethylene glycol-bis (β-aminoethyl ether)N,N,N',N'-tetraacetic acid (EGTA), 2 Mg2ATP, 0.1 GTP lithium salt (GTP), and 10
HEPES-CsOH, pH to 7.2 In some experiments GTP was replaced with 100 µM
guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-β-S) to inhibit G protein
activation.
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All chemical reagents used were of analytical grade. Ibogaine
hydrochloride, (+)-pentazocine, haloperidol, 1,3-Di-O-tolylguanidine (DTG),
metaphit, and tetrodotoxin were purchased from Sigma Chemical (St. Louis,
MO).
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RESULTS

To determine whether sympathetic and parasympathetic neurons may be
the target of sigma receptor ligands, autonomic neurons were first screened for
the expression of transcripts encoding the sigma-1 receptor using RT-PCR
techniques. Oligonucleotide primers were designed to span introns 2 and 3 of
the sigma-1 gene to differentiate between cDNA and genomic DNA. RT-PCR of
total RNA extracts from SCG and ICG ganglia and associated tissue (e.g.,
cardiac myocytes, Schwann cells, and fibroblasts) showed that sigma-1 receptor
transcripts are expressed in these cells (Figure 1A). However, since sigma-1
receptors have been found in nonneuronal cells, it seemed prudent to test for the
presence of sigma-receptor transcripts at the single-cell level. Using single-cell
RT-PCR techniques, transcripts encoding the sigma-1 receptor were shown to be
expressed in individual ICG and SCG neurons (Figure 1B). Sigma-1 receptor
transcripts were detected in 57% of ICG neurons (4 of 7) and 67% of SCG
neurons (4 of 6). Sequencing of the products obtained from individual autonomic
neurons indicated exact sequence homology to the known rat brain sigma-1
receptor (Seth et al., 1998). Splice variants of the sigma-1 receptor have been
reported in the rat and mouse as submissions to GenBank (accession numbers
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AF087827 and AF226605, respectively). The oligonucleotide primers used here
were specifically designed to detect conventional sigma-1 transcripts and both of
these sequence variants, but no such isoforms were detected in these cells.

Sigma Receptor-Mediated Attenuation of Ca2+ Channel Currents
Sigma receptors have been shown to modulate calcium homeostasis in
various cell types. One of the mechanisms by which sigma receptors appear to
modulate cellular calcium is through attenuation of calcium influx through the cell
membrane. However, the effects of sigma receptor activation on calcium channel
function have not been determined.
Ca2+ channel currents were isolated by inhibiting Na+ currents with
extracellular TTX, and K+ channels with intracellular Cs+ and extracellular TEA
and Ba2+. Ba2+ was used as the charge carrier through open calcium channels in
most experiments for reasons discussed in METHODS. The effect of sigma
ligands on the Ba2+ current-voltage (I-V) relationship was examined using brief
(250ms) step depolarizations of 10-mV increments ( 50 to +90 mV) from a
holding potential of

90 mV. Figure 2A shows a family of depolarization-

activated Ba2+ currents (IBa) recorded from a single SCG neuron in the absence
(Control) and presence of the sigma receptor ligand, haloperidol (10 µM). Bath
application of haloperidol depressed peak IBa amplitude at all potentials positive
to

10 mV within 3 min of drug application. Figure 2B shows the average I-V

relationship obtained for six neurons before (Control) and after bath application of
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10 µM haloperidol. Under control conditions, IBa was activated at approximately
30 mV and the I-V relation was maximal at 0mV, reversing at approximately +50
mV. In the presence of haloperidol, the I-V relationship exhibited similar voltage
dependence, but the peak IBa amplitude was reduced at all voltages. At 0 mV, IBa
decreased from a control value of 1,565 ± 76 pA to

969 ± 222 pA in the

presence of 10 µM haloperidol, (n= 6). Inhibition of Ca2+ channel currents
occurred to a similar degree when Ca2+ was the charge carrier (data not shown).
Bath application of 100 µM Cd2+ completely blocked the depolarizationactivated Ba2+ current, both in the absence and the presence of haloperidol (data
not shown). The observed Cd2+ block, coupled with the lack of shift in the
reversal potential for the depolarization-activated currents (Figure 2B) in the
presence of sigma ligands, suggests that these drugs are not activating or
inhibiting another membrane conductance.

Concentration-Dependent Inhibition of IBa by Sigma Ligands
To determine whether the effect of haloperidol on Ca2+ channels is
mediated by sigma receptor activation, the ability of various sigma ligands to elicit
a similar response was assessed. Figure 3A shows representative currents
recorded from three different SCG neurons (1-3) in the absence (Control) and
presence of haloperidol, (+)-pentazocine, and DTG. The peak inward IBa was
measured before and after exposure to various concentrations of the sigma
ligands haloperidol, (+)-pentazocine, DTG, and ibogaine. For these experiments,
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each cell was exposed to a minimum of three drug concentrations. A plot of the
mean peak IBa as a function of drug concentration is shown in Figure 3B.
Haloperidol had the greatest potency of the ligands tested, and a fit of the data
using the Hill equation gave a half-maximal inhibitory concentration (IC50) value
of 6 µM. Similarly, the IC50 values for ibogaine, (+)-pentazocine and DTG were
31, 61, and 133 µM, respectively, and the Hill coefficient was 1.1 for all drugs.
Maximum inhibition of IBa by all sigma ligands tested was ≥95%.
The effect of sigma ligands on Ca2+ channel current amplitude was
reversible on wash out. Figure 4A shows a family of Ba2+ currents evoked by
step depolarizations from a single neuron in the absence (Control), presence
(+DTG), and following wash out for the indicated time points of the sigma ligand,
DTG. Following inhibition of IBa, the current recovered to near control levels
within 5 min of wash out (Figure 4B). Similar reversal of inhibition was observed
for all sigma ligands tested here. No significant rundown of IBa was observed in
recordings ≤45 min.

Sigma Receptor Antagonist Depresses the Effect of DTG on Ca2+ Channels
To confirm whether the effect of sigma ligands on Ca2+ channels was
mediated by activation of a sigma receptor, the irreversible sigma receptor
antagonist, metaphit was used. Metaphit is known to rapidly and specifically
acetylate sigma receptors, which results in a block of ligand binding (Bluth et al.,
1989). Isolated SCG neurons were preincubated in 50 µM metaphit (in PSS) for
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10 min at room temperature. Following wash out of drug, Ba2+ current amplitude
was similar to that recorded in control experiments (no preincubation; Figure 5A),
suggesting that preincubation in metaphit alone had no effect on Ca2+ channel
currents. On application of DTG, Ba2+ current amplitude was depressed under
both conditions, but in cells preincubated in metaphit the response to DTG was
obtunded. Figure 5B shows a bar graph of relative mean IBa amplitude recorded
in the presence of 100 µM DTG in control neurons (DTG; n = 7) or neurons
preincubated in metaphit (Metaphit+DTG; n=6). DTG decreased mean IBa by 28
± 4% in cells exposed to metaphit, whereas in control cells the decrease was 49
± 4%. The difference in DTG attenuation of IBa under both conditions was
statistically significant (P<0.01).

Sigma Receptors Inhibit Ca2+ Channels in Parasympathetic Neurons
To determine whether similar modulation of Ca2+ channels also occurs in
parasympathetic ICG neurons, the effect of sigma receptor ligands on these
channels was studied. For these experiments haloperidol, ibogaine, (+)pentazocine, and DTG were used at concentrations near the IC50 value for IBa
inhibition, as determined in SCG neuron. Figure 6A shows currents evoked from
four different neurons in the absence (Control) and presence of the indicated
sigma ligands. A plot of the mean inhibition of IBa evoked by these sigma ligands
is shown in Figure 6B and is consistent with the observations made in SCG
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neurons. As in the case of SCG neurons, sigma ligands maximally inhibited peak
IBa in intrinsic cardiac neurons by ≥95% (data not shown).

Effects of Haloperidol on Ca2+ Channel Inactivation
Some receptors that modulate Ca2+ channels, such as M4-muscarinic and
α2-adrenergic receptors have been shown to differentially affect the rapid and
slow component of Ca2+ channel current decay (Cuevas and Adams 1997; Xu
and Adams 1993). To determine whether sigma receptors have a similar effect
on Ca2+ channel inactivation kinetics, Ca2+ channel currents were evoked by step
depolarization (2 s) to 0 mV from a holding potential of

90 mV in the absence

and presence of 10 µM haloperidol. Figure 7A shows representative responses
recorded from a single SCG neuron. Under control conditions, the timedependent inactivation of IBa was biphasic, and best fit by the sum of two
exponential functions with time constants of 198 ms ( 1) and 2.2 s ( 2). In the
presence of haloperidol, the inward current was also best fit by the sum of two
exponential functions, but both

1

and

2

were decreased to 117 ms and 1.1 s,

respectively. Following wash out of haloperidol,

1

and

2 returned

to near control

levels and were 171 ms and 1.5 s, respectively. In five similar experiments, the
time course of IBa decay was best fit by the sum of two exponential functions with
mean time constants of 100 ± 15 ms ( 1) and 1.2 ± 0.1 s ( 2). In all SCG neurons
studied, haloperidol decreased both

1

and

2

in a statistically significant manner

(P < 0.01), and mean time constants were 62 ± 11 ms ( 1) and 711 ± 146 ms ( 2;
25

n = 5). The peak amplitude of each of the two components of the fit was also
depressed, with the amplitude of the first component decreasing by 40 ± 11%
and that of the second component by 35 ± 7%. In all cells tested, the effect of
haloperidol on the time course of decay of IBa was reversible on wash out and
mimicked by ibogaine (data not shown).
The effect of haloperidol (10 µM) on steady-state inactivation of Ca2+
channels in rat SCG neurons was studied using a double pulse protocol.
Neurons were initially held at

90 mV, and 10-s prepulses from

120 to +10 mV

were applied in 10-mV increments prior to a voltage step to +20 mV (20 ms) to
activate (open) the available Ca2+ channels. A plot of the relative peak current
amplitude [IBa/IBa(max)] as a function of prepulse voltage is shown in Figure 7B (n
= 6). The steady-state inactivation of IBa under control conditions exhibited a
sigmoidal dependence on voltage and was best fit with a single Boltzmann
function according to the equation
IBa = IBa(max)/{1 + exp{(V-Vh)/k]}
A fit of the mean relative I-V relationship exhibited half-maximal steady-state
inactivation (Vh) at

27 mV and had a slope parameter (k) of

12. In the

presence of haloperidol, however, the voltage dependence of steady-state
inactivation was best fit by a two-component Boltzmann distribution
IBa = i1(IBa(max)/{1 + exp{(Vh1-V)/k1]}) + i2(IBa(max)/{1 + exp{(Vh2-V)/k2]})
where i1 and i2 represent the fraction contributed by each component to the final
function. The values for i1 and i2 were 0.21 and 0.78, respectively. The first
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component was half-maximally activated (Vh1) at

13 mV and had a slope

parameter (k1) of

6.3, whereas the second component was half-maximally

activated (Vh2) at

53 mV and had a slope parameter (k2) of

14.9.

Effects of Haloperidol on the Voltage Dependence of Ca2+ Channel
Activation
The voltage dependence of activation was examined by measuring tail
current amplitude. Neurons were held at

90 mV, and brief steps (20 ms) to

various test potentials ( 50 to +100) were applied prior to repolarization to

90

mV. Figure 8A shows Ba2+ currents obtained in the absence and presence of
haloperidol (10 µM) in response to voltage steps to the indicated potentials and
the ensuing tail currents elicited on repolarization to

90 mV. The corresponding

I-V relationship obtained for the peak tail current amplitudes of six neurons is
shown in Figure 8B. Haloperidol significantly reduced the peak tail current
amplitude at all voltages from

10 to +100 mV in a reversible manner. However,

at 0mV haloperidol decreased peak IBa tail current amplitude by 57% but by 73%
at +50 mV. This effect does not appear to be a use-dependent phenomenon
since IBa tail current amplitude did not decrease during a train of brief
depolarizations (5 pulses, 20 ms) to +80 mV or by reversing the voltage protocol
(data not shown). Also, at voltages where Ca2+ channels were maximally
activated, inhibition by haloperidol was comparable (+80 mV, 77%; +90 mV, 78%;
+100 mV, 76%). The reason for greater depression of IBa tail current amplitude
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by haloperidol at higher depolarizations is a drug-induced shift in Ca2+ channel
activation.
Figure 8C shows a plot of the mean peak IBa tail current amplitude
normalized to maximum IBa tail current amplitude in the absence and presence of
haloperidol. Ca2+ channels exhibit sigmoidal activation at potentials positive to
40 mV under both conditions. Data points were best fit using a two-component
Boltzmann distribution (Eq.2). For control, i1 and i2 were 0.48 and 0.52,
respectively, whereas in the presence of haloperidol i1 and i2 were 0.70 and 0.20,
respectively. Half-maximal activation of the first component (Vh1) shifted from
mV in the absence (control) to

4

13 mV in the presence of haloperidol, while the

second component (Vh2) shifted from +38 mV (control) to +22 mV (+haloperidol).
This sigma receptor-induced shift in the voltage dependence of activation results
in tail currents of greater amplitude at more negative potentials and is thus
responsible for the difference in percent inhibition of Ba2+ tail currents by
haloperidol at low and high depolarizations. The effects of haloperidol on the
voltage dependence of Ca2+ channel steady-state inactivation and activation
were reversible on wash out and were mimicked by ibogaine (data not shown).

Effect of Intracellular Dialysis with GTP and GDP- -S on Sigma Receptor
Inhibition of IBa
In some systems, sigma receptors have been shown to couple to effector
targets via a signal transduction cascade involving a G protein. To determine
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whether a G protein is involved in the sigma receptor-mediated modulation of
Ca2+ channels in autonomic neurons, intrinsic cardiac neurons were dialyzed with
pipette solution containing either 100 µM GTP or 100 µM GDP-β-S. In neurons
dialyzed with GTP, sigma receptor-induced inhibition of IBa was similar to that
observed in neurons electrically accessed using the perforated-patch method.
Figure 9A shows representative currents in response to step depolarizations from
90 to 0 mV recorded from two neurons dialyzed with either GTP (top traces) or
GDP-β-S (bottom traces) in the absence and presence of 10 µM haloperidol. A
summary of the peak IBa amplitudes elicited on depolarization to 0 mV,
normalized to their respective control values, under the different experimental
conditions is presented in Figure 9B. Haloperidol decreased IBa by 68 ± 8% (n =
5) in neurons dialyzed with pipette solution containing GTP and by 62 ± 3% (n =
6) in neurons dialyzed with GDP-β-S. The difference between these two
experimental groups was not statistically significant. DTG inhibition of IBa was
reversible on wash out of drug when cells were dialyzed with either GTP or GDPβ-S (data not shown).
To determine whether the dialysis with GDP-β-S was sufficient to block G
protein-mediated events, these cells were also exposed to 100 µM ACh to elicit
muscarinic receptor-evoked inhibition of Ca2+ channels. Muscarinic receptors
have been shown to couple to Ca2+ channels via a pertussis toxin-sensitive G
protein in intrinsic cardiac neurons (Cuevas and Adams 1997). Following cell
dialysis with GTP containing pipette solution, ACh depressed IBa by 40 ± 6% (n =
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3). This ACh-mediated inhibition was reduced to 17 ± 4 in cells dialyzed with
GDP-β-S (n = 3), which was significantly different from the reduction observed
when GTP was used.
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Figure 2.1 Detection of sigma-1 receptor transcripts in rat ICG and SCG. A:
RNA from rat ICG and SCG were reverse transcribed and amplified via PCR
using oligonucleotide primers specific for the sigma-1 receptor (sense,
GTCTTTTGCACGCCTCGCTGTCTGAGTACG; antisense,
ACCCTCTCTGGATGGAGGTGAGT GC). B: RT-PCR reaction results for 2
isolated neurons from rat ICG and SCG using the sigma-1 primers. A and B:
arrows indicate predicted size for the sigma-1 receptor product (639 bp), and
standards are 100 bp ladder.
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Figure 2.2 Inhibition of Ca2+ channel currents in sympathetic neurons by the
sigma receptor agonist, haloperidol. A: family of depolarization-activated Ba2+
currents recorded from a single SCG neuron in the absence (Control) and
presence of 10 µM haloperidol. B: whole cell current-voltage relation obtained in
the absence ( ) and presence of 10 µM haloperidol ( ). Data points represent
means ± SE for 6 cells.
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Figure 2.3. Dose-dependent inhibition of depolarization-activated Ca2+ channels
by sigma receptor ligands in rat sympathetic neurons. A: whole cell currents
evoked from 3 SCG neurons (1-3) by step depolarizations to 0 mV from a holding
potential of

90 mV in the absence (Control) and presence of haloperidol, (+)-

pentazocine and 1,3-Di-O-tolylguanidin (DTG) at the indicated concentrations. B:
peak whole cell IBa amplitude, evoked by depolarizing to 0 mV from

90 mV,

normalized to control and plotted as a function of sigma ligand concentration.
Data points represent means ± SE for 5-7 neurons. The curves represent best fit
to the data using the Hill equation. Half-maximal inhibition was 6 µM for
haloperidol (■), 31 µM for ibogaine (◊), 61 µM for (+)-pentazocine (●), and 133
µM for DTG (∆), and the Hill coefficient was 1.1 for all compounds.
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Figure 2.4 Reversibility of DTG-induced block of depolarization-activated Ca2+
channels. A: family of depolarization-activated Ca2+ channel currents recorded
from a single rat SCG neuron in the absence (Control) and presence of bathapplied 1 mM DTG (+DTG), and following wash out of drug for the indicated time
periods. B: peak Ba2+ current amplitudes before application (○), during
application (●), and after removal (○) of 1 mM DTG for the cell in A. Values are
plotted as a function of time. Gap represents period during which lower
concentrations of DTG were applied, with 1 mM DTG application commencing at
t =13 min.
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Figure 2.5 Attenuation of DTG-mediated inhibition of Ca2+ channels by the sigma
receptor antagonist, metaphit. A: depolarization activated ( 90 to 0 mV) Ba2+
currents recorded from 2 SCG neurons in the absence (Control, Metaphit) and
presence of 100 µM DTG (DTG, Metaphit + DTG). Bottom traces are from a
neuron preincubated in metaphit (50 µM) in physiological saline solution (PSS),
(10 min). B: bar graph of the relative mean peak IBa (±SE) obtained by step
depolarizations ( 90 to 0 mV) in control cells (DTG) or cells preincubated in
metaphit (50 µM, 10 min; Metaphit + DTG) following bath application of 100 µM
DTG. Current amplitudes were normalized to their respective controls (absence
of DTG). Data were collected from 7 neurons for each condition, and asterisk
denotes significant difference between the groups (P < 0.01)
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Figure 2.6 Inhibition of Ca2+ channel currents in rat ICG neurons by sigma
receptor ligands. A: Ba2+ currents evoked by step depolarizations to 0 mV from
90 mV recorded from 4 parasympathetic ICG neurons in the absence (Control)
and presence of ibogaine, DTG, (+)-pentazocine, and haloperidol at the indicated
concentrations. B: peak whole cell Ba2+ current amplitude normalized to control
recorded in the presence of haloperidol (HAL), ibogaine (IBO), (+)-pentazocine
(PTZ), and DTG. Bars represent means ± SE for 3-5 ICG neurons.
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Figure 2.7 Sigma receptor modulation of time-dependent and steady-state
inactivation of Ca2+ channels in SCG neurons. A: Ba2+ currents evoked from a
single neuron by 2-s depolarizations to 0 mV from a holding potential of

90 mV

in the absence (Control), presence of 10 µM haloperidol (Haloperidol), and
following wash out of drug (Wash). Solid lines represent a best fit of the time
course of current decay with the sum of 2 exponential functions. B: relative Ba2+
current amplitude as a function of prepulse amplitude in the absence (○) and
presence (●) of 10 µM haloperidol. Data points represent means ± SE for 6
neurons. Solid lines represent best fit to the data with a single (control) or 2component (haloperidol) Boltzmann distribution.
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Figure 2.8 Sigma receptor evoked shift in voltage dependence of Ca2+ channel
activation. A: Ca2+ channel tail currents evoked from a single neuron by
repolarization to

90 mV from the indicated potentials in the absence (Control)

and presence of 10 µM haloperidol (Haloperidol). The time scale is increased 5fold at the start of repolarization. Mean peak tail current amplitude (B) and
relative peak Ba2+ tail current amplitude (C) evoked by repolarization to

90 mV

following a brief depolarization to the indicated potentials in the absence (○) and
presence (●) of 10 µM haloperidol. Data points represent means ± SE for 6
neurons. Solid lines in C represent best fit to the data using a 2-component
Boltzmann distribution
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Figure 2.9 Sigma receptor inhibition of Ca2+ channels is not blocked by
intracellular GDP-β-S. A: depolarization activate ( 90 to 0 mV) Ba2+ currents
recorded from neurons dialyzed with pipette solutions containing either 100 µM
GTP (top traces) or GDP-β-S (bottom traces) in the absence (Control) or
presence of 10 µM haloperidol (Haloperidol). B: peak IBa recorded from neurons
dialyzed with either GTP or GDP-β-S in the presence of 10 µM haloperidol or 100
µM ACh. Currents are normalized to their respective controls (absence of drug).
Asterisk denotes significant difference between groups of cells exposed to ACh.
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DISCUSSION

The results presented here provide the first evidence of sigma receptors
being expressed in mammalian parasympathetic and sympathetic neurons.
Transcripts encoding sigma-1 receptors were detected in individual neurons from
ICG and superior cervical ganglia in neonatal rats. Sigma receptors were shown
to inhibit all Ca2+ channel subtypes present in neurons of both autonomic ganglia
with high efficacy. Furthermore, sigma receptors were demonstrated to differ
from other modulators of Ca2+ in these cells on the basis of their effects on the
biophysical properties of the channels and the signal transduction cascade
coupling them to these Ca2+ channels.
Two pharmacologically distinct subtypes of sigma receptors have been
identified: sigma-1 and sigma-2 receptors, respectively. Photoaffinity labeling
experiments with sigma receptor-specific ligands have also revealed the
presence of a 25-kDa polypeptide in guinea pig brain corresponding to the sigma1 receptor and a polypeptide doublet of 18 and 21 kDa that is believed to
represent the sigma-2 receptor (Hellewell and Bowen 1990). The mammalian
sigma-1 receptor has been cloned in several species including guinea pig,
human, and rat (Hanner et al., 1996; Kekuda et al., 1996; Seth et al., 1998).
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These receptors are expressed in the brain and in several peripheral tissues and
organs (Walker et al., 1990). Because of the presence of sigma-1 receptors in
cardiac muscle (Ela et al., 1994), and possibly other tissues associated with ICG
ganglia or in support cells in the SCG, we used single-cell RT-PCR techniques to
demonstrate that transcripts for this receptor are present specifically in autonomic
neurons. The sequences of the sigma-1 receptor transcripts cloned from both
ICG and SCG neurons were identical to that reported for the rat brain sigma-1
receptor (Seth et al., 1998). No splice variations of the sigma-1 receptor were
detected in these neurons. Sequences for two isoforms of the sigma-1 receptor
have been submitted previously to GenBank (Mei and Pasternak 1998; Wang et
al., 2000). One of these isoforms, sigma-1β receptor, was cloned from mouse
and is reported to have sigma-2-like binding activity (Wang et al., 2000).
However, transcripts encoding these truncated forms of the sigma-1 receptor
were not observed, indicating that they do not mediate the cellular responses to
sigma ligands reported in this study.
In the present study, the use of sigma receptor agonists suggests that
sigma receptors inhibit Ca2+ channels in neurons from parasympathetic ICG
ganglia and sympathetic superior cervical ganglia. These agonists were shown
to inhibit Ca2+ channels in over 90% of the cells tested (n>100). In autonomic
neurons, various cell membrane receptors have been shown to be coupled to
Ca2+ channels. In mammalian ICG neurons, M4 muscarinic, α-adrenergic,
neuropeptide Y, and µ-opioid receptors have all been shown to depress Ca2+
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channel currents (Adams and Trequattrini 1998; Cuevas and Adams 1997; Jeong
and Wurster 1997a; Kennedy et al., 1998; Xu and Adams 1993). However,
maximum inhibition of peak Ca2+ by activation of these receptors is ≤75%, and
their primary target is N-type calcium channels, which account for ~70% of the
whole cell calcium current in these cells (Cuevas and Adams 1997; Jeong and
Wurster 1997a; Xu and Adams 1993). In contrast, activation of sigma receptors
in these neurons inhibits ≥95% of the peak current, indicating that all Ca2+
channel types are affected. It has been reported that these cells express N-, L-,
P/Q-, and R-type calcium channels (Cuevas and Adams 1997; Jeong and
Wurster 1997b; Xu and Adams 1993).
The sigma receptor inhibition of heterogeneous populations of Ca2+ may
have significant physiological implications. Attenuation of N-type Ca2+ channels
by ω-conotoxin GVIA fails to block synaptic transmission in parasympathetic
ganglia, but broad-spectrum Ca2+ channel inhibitors, such as cadmium, eliminate
excitatory postsynaptic potentials (Seabrook and Adams 1989). Inhibition of
multiple classes of Ca2+ channels may contribute to the reported sigma receptormediated decrease in guinea pig ileum longitudinal muscle contraction (Campbell
et al., 1989; Kinney et al., 1995). It has been proposed that a decrease in ACh
release is responsible for this attenuation in muscle contraction (Campbell et al.,
1989) and block of presynaptic Ca2+ would depress transmitter release.
Therefore activation of sigma receptors may block signaling through autonomic
ganglia and inhibit modulation of effector targets by peripheral neurons. In the
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cardiovascular system, inhibition of parasympathetic input to the heart may
account for the increased heart rate, arrhythmias, and sudden cardiac death
observed in some patients during therapy with haloperidol (Mehta et al., 1979;
Settle and Ayd 1983; Turbott and Cairns 1984). Furthermore, haloperidol evokes
a prolongation of the QT interval in the electrocardiogram (Kriwisky et al., 1990),
which is similar to that induced by atropine-mediated vagal block (Annila et al.,
1993).
In addition to affecting a broader population of Ca2+ channel types than
other endogenous modulators of autonomic Ca2+ channels, activators of sigma
receptors have profoundly different effects on Ca2+ channel biophysics. Whereas
ACh and norepinephrine (NE), for example, have no effects on the steady-state
inactivation of Ca2+ channels (Cuevas and Adams 1997; Xu and Adams 1993),
sigma ligands shift the steady-state inactivation curve to more negative
potentials. The fact that the voltage dependence of inactivation was best fit by a
one-component Boltzmann distribution in the absence of sigma receptor
activation but by a two-component Boltzmann distribution in the presence of
haloperidol suggests that sigma receptors may not equally modulate steady-state
inactivation in all Ca2+ channel subtypes.
Activation of sigma receptors also altered the voltage dependence of
activation of Ca2+ channels in a manner distinct from other known Ca2+ channel
inhibitors. In the presence of sigma receptor agonists, the Ca2+ channel
activation curve was shifted toward more negative potentials. Other inhibitors of
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Ca2+ channels, such as µ-opioid, muscarinic and α-adrenergic agonists shift the
activation curve to more positive potentials (Adams and Trequattrini 1998;
Cuevas and Adams 1997; Xu and Adams 1993). Thus stronger depolarizations
are required in the presence of these agents to activate the same number of Ca2+
channels. The shift in the Ca2+ channel activation curve toward more positive
potentials has been explained by a "willing-reluctant" model first proposed by
Bean (Bean 1989). According to this model, Ca2+ channels are converted in the
presence of a modulator from a "willing" state to a "reluctant" state that requires
stronger depolarization to open the channel. Such a shift in the voltage
dependence of activation is not observed here. Further evidence for the lack in
willing to reluctant shift in the presence of sigma ligands is provided by
experiments in which prolonged depolarizations were applied to activate Ca2+
channels. The fast component of the inward Ca2+ current ( 1), represents
channels in the willing state, and this component was not preferentially inhibited.
In contrast, ACh and NE primarily depress the fast inactivating component ( 1) in
long depolarizations and have little effect on the amplitude of

2 (Cuevas

and

Adams 1997; Xu and Adams 1993). However, ACh also activates "voltageindependent" mechanisms of Ca2+ channel inhibition that result in depression of
IBa at all voltages tested (Cuevas and Adams 1997; Mathie et al., 1992), as is
observed here. Similarly, NE inhibition of Ca2+ channel activation in rat ICG
neurons exhibits voltage-dependent and -independent components (Xu and
Adams 1993). One of the outcomes of sigma receptor-mediated increase in the
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rate of Ca2+ channel inactivation and attenuation of the amplitude of both
2

1

and

is a greater decrease in net Ca2+ entry through the channels compared with

other Ca2+ channel inhibitors.
Previous studies have suggested a possible relationship between sigma
receptors and calcium channels. Dextromethorphan, a nonselective sigma
receptor agonist, decreased K+ depolarization-evoked Ca2+ uptake into brain
synaptosomes and PC12 cells (Carpenter et al., 1988). The half-maximal
inhibition of Ca2+ uptake by dextromethorphan was consistent with the effect
being mediated by a sigma-2 site, and sigma-2 receptors have been reported in
brain and PC12 cells (Hellewell and Bowen 1990; Reid et al., 1990). It has also
been suggested that some sigma ligands, including dextromethorphan, inhibit
Ca2+ currents by directly interacting with Ca2+ channels (Church and Fletcher
1995; Flaim et al., 1985). Conversely, in frog melanotrophs, micromolar
concentrations of (+)-pentazocine have been shown to enhance calcium
conductances through activation of sigma receptors (Soriani et al., 1999). The
present study shows that structurally dissimilar sigma ligands are able to
modulate the biophysical properties of Ca2+ channels. Since these ligands have
similar effects on the biophysical properties of the channels, it is unlikely that they
would be acting on different sites of the channel. Although the exact binding site
for these drugs on the cloned sigma-1 receptor has not been identified, any
single site that permits binding to such a broad array of drugs is likely to be quite
complex (Walker et al., 1990) and conserved. Thus the lack of any significant
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homology between Ca2+ channels and the cloned sigma-1 receptor suggests that
the effects of sigma ligands are likely mediated by a sigma receptor and not a
direct effect on the Ca2+ channel. The argument against a direct effect of sigma
ligands on Ca2+ channels is significantly strengthened by the observation that the
sigma receptor antagonist, metaphit, blocks the DTG-mediated attenuation of
Ca2+ channels.
Consistent with the effects of sigma ligands on Ca2+ channels being
mediated by specific binding of the drugs to a sigma receptor is the finding that
the rank order potency and IC50 values for the various sigma ligands tested here
are in agreement with those reported previously for sigma-2 receptors. Sigma-2
receptors have been shown to modulate Ca2+ release from intracellular stores in
human SK-N-SH neuroblastoma cells (Vilner and Bowen 2000). The rank order
potency reported in that study, haloperidol > ibogaine > (+)-pentazocine ≈ DTG,
and micromolar EC50 values are in agreement with our findings. Sigma-2
receptors have also been reported to mediate the inhibition of guinea pig ileum
longitudinal muscle contraction (Kinney et al., 1995). In that study, haloperidol
was shown to depress electrically evoked contractions with an IC50 nearly
identical to that reported here (~6 µM). In primary cultures of rat frontal cortical
neurons, sigma-2 receptor activation blocked N-methyl-D-aspartate (NMDA)
mobilization of intracellular free Ca2+ (Hayashi et al., 1995). The IC50 for
haloperidol and (+)-pentazocine inhibition of peak free Ca2+ were ~6 and 40 µM,
respectively, also in agreement with the values reported here for these drugs.
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One of the strongest lines of evidence for sigma-2 receptors mediating the
inhibition of Ca2+ channels in autonomic neurons is our observation that ibogaine,
a sigma-2-selective agonist (Bowen et al., 1995), exhibits greater potency than
(+)-pentazocine. The affinity of sigma-1 receptors for (+)-pentazocine is ~2,000fold greater than for ibogaine, whereas the affinity of sigma-2 receptors for
ibogaine is ~6-fold higher than for (+)-pentazocine (Vilner and Bowen 2000). The
IC50 for ibogaine inhibition of IBa in these autonomic neurons is two-fold greater
than that determined for (+)-pentazocine.
The primary mechanism by which other known modulators of Ca2+ in
autonomic neurons depress Ca2+ currents is via the activation of pertussis toxinsensitive G proteins (Adams and Trequattrini 1998; Cuevas and Adams 1997; Xu
and Adams 1993). However, no such G protein appears to be implicated in the
signal transduction cascade coupling sigma receptors and Ca2+ channels in these
cells, since intracellular dialysis with GDP-β-S failed to inhibit the effects of sigma
ligands. Furthermore, the inability of cell dialysis to block the effects of sigma
receptors suggests that a diffusable cytosolic second messenger is likely not
involved. Similarly, sigma receptors have been shown to modulate K+ channels
in rat pituitary cells through a membrane-delimited signaling pathway that does
not incorporate a G protein (Lupardus et al., 2000).
Taken together, molecular biology studies and pharmacological studies
conducted here suggest that both sigma-1 and sigma-2 receptors are expressed
in ICG and superior cervical ganglion neurons. However, our experiments
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indicate that only the sigma-2 receptor, which remains to be cloned, couples to
Ca2+ channels in these cells. Given that the sigma-2 receptor has been shown to
be a distinct molecular entity (Hellewell and Bowen 1990), it is doubtful that the
sigma receptor shown to modulate Ca2+ channels here is a modified form of the
sigma-1 receptor gene product. Thus the cellular function of the sigma-1
receptors found in these autonomic neurons remains to be determined.
In conclusion, rat ICG and SCG neurons express sigma-1 and sigma-2
receptors, and activation of these receptors alters the biophysical properties of
Ca2+ channels and attenuates whole cell Ca2+ channel currents.
Pharmacological experiments suggest that the modulation of Ca2+ channels is
mediated by sigma-2 receptors. Because of the importance of Ca2+ channels in
the function and regulation of the autonomic nervous system, sigma receptors
are likely to have a significant role in the modulation of autonomic nerve activity
and thus on regulation of the cardiovascular system and other effector targets.
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CHAPTER 3
SIGMA RECEPTOR ACTIVATION BLOCKS POTASSIUM CHANNELS AND
DEPRESSES NEUROEXCITABILITY IN RAT ICG NEURONS

INTRODUCTION

Sigma receptors are non-opioid, non-phencyclidine receptors that are
distributed throughout the central and peripheral nervous system. These
receptors have high affinity for numerous drugs in clinical use including
psychotherapeutic agents such as antipsychotics (Su,1982) and selective
serotonin reuptake inhibitors (Narita et al., 1996). At least two subtypes of sigma
receptors have been classified based on the findings from biochemical and
radioligandbinding experiments, and have been designated as sigma-1 and
sigma-2 (Hellewell and Bowen,1990). However, to date, only the sigma-1
receptor has been cloned (Hanner et al., 1996). These receptors have been
implicated in physiological processes such as learning and memory and in
pathophysiological disorders such as schizophrenia and depression (Snyder and
Largent,1989). More recently, sigma receptors have been linked to the
development of drug dependence (Ujike et al., 1996). Sigma receptors also
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appear to play a role in the regulation of the cardiovascular system, as suggested
by pharmacological studies using sigma receptor ligands. For example, it hasbeen shown that the sigma receptor ligand, DuP 754, raises the threshold of
ventricular fibrillation in rats (Lishmanov et al., 1999). Conversely, the sigma
receptor agonists, (+) SKF-10,047, 1,3-Di-Otolyguanidin(DTG), and (+)-3-[3hydroxyphenyl]-N-(1-propyl)piperidine, have been shown to produce tachycardia
by activating central and peripheral sigma receptors (Wu and Martin, 1989;
Lishmanov et al., 2000). Some of the effects of sigma receptor ligands on the
cardiovascular system are likely due to activation of sigma receptors on cardiac
muscle. Sigma receptors have been detected in cardiac myocytes from neonatal
and adult rats, and stimulation of these receptors was shown to elicit direct
inotropic and chronotropic effects on cardiac muscle (Ela et al., 1994; Novakova
et al., 1995). However, sigma receptors have also been found in autonomic
neurons that regulate the cardiovascular system and modulation of the electrical
activity of these neurons by endogenous or exogenous sigma ligands is likely to
have profound effects on cardiovascular function. Mammalian intracardiac
ganglia (ICG) mediate all parasympathetic input to the heart and serve as the
common final pathway for autonomic regulation of cardiac function. Sigma
receptor ligands, including haloperidol, (+) pentazocine, DTG and ibogaine, were
shown to inhibit high voltage-activated calcium channels in intrinsic cardiac
neurons. The pharmacological profile of the sigma receptor mediating these
effects was consistent with a sigma-2 receptor (Zhang and Cuevas, 2002). While
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sigma-1 receptor transcripts were detected in ICG neurons, no cellular effects
have been attributed to this receptor. One possible role for sigma-1 receptors in
these cells is the modulation of voltage-activated K+ channels. Recent
experiments have shown that currents mediated by Kv1.4 and Kv1.5 are
depressed by the sigma ligand (+)-SKF 10,047 in oocytes injected with Kv
subunits and the sigma-1 receptor, but not in oocytes injected with the Kv
subunits alone (Aydar et al., 2002). Furthermore, sigma-1 receptors were shown
to alter the kinetic properties of Kv1.4 channels in the absence of ligand, and
Kv1.4 and Kv1.5 coimmunoprecipitated with the sigma-1 receptor (Aydar et al.,
2002), which led those investigators to propose that the sigma-1 receptor
functions as a ligand-regulated auxiliary K+ channel subunit. The inhibition of
delayed outwardly rectifying K+ channels, such as Kv1.5,by verapamil has been
shown to depress AP firing in intrinsic cardiac neurons, and this phenomenon
has been implicated in the tachycardia associated with this type IV antiarrhythmic
drug (Hogg et al., 1999). However, it remains to be determined if sigma-1
receptors couple to voltage-activated K+ channels in ICG neurons, and if sigma
receptor activation can alter the active membrane proprieties of these cells. By
regulating the function of K+ channels in parasympathetic ICG neurons, sigma-1
receptors, and therefore drugs that act on these receptors, may have significant
influence on the heart. Experiments were undertaken to determine the effects of
sigma receptors on currents mediated by voltage-activated K+ channels (IK) and
the active membrane properties of ICG neurons from neonatal rats. Sigma
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receptors were shown to decrease the peak amplitude of currents mediated by
delayed outwardly-rectifying K+ channels (IK(DR)), large conductance Ca2+sensitive K+ channels (IBK), and the M-current (IM). The rank-order potency of K+
channel inhibition by different sigma ligands suggest that the effect is mediated
by sigma-1 receptors. Neither cell dialysis nor intracellular application of GDP-ßS blocked the effects of sigma-1 receptors on IK, consistent with a direct
interaction between sigma-1 receptors and the K+channels. Activation of sigma1 receptors also decreased AP firing and changed the AP configuration in ICG
neurons. Therefore, sigma-1 receptor activation depresses the excitability of ICG
neurons and is likely to attenuate parasympathetic input to the heart.
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METHODS

Preparation of Cell Culture
The isolation and culture of neurons from neonatal rat ICG ganglia has
been described previously (Cuevas and Adams, 1994). Briefly, neonatal rats (27 day old) were euthanized by decapitation and the hearts excised and placed in
a physiological saline solution containing (mM): 140 NaCl, 3 KCl, 2.5 CaCl2, 0.6
MgCl2, 7.7 glucose and 10 histidine; pH to 7.2 with NaOH. Atria were removed
and incubated for 1 h at 37 oC in physiological saline solution containing 1 mg/ml
collagenase (Type 2, Worthington). Following enzymatic treatment, clusters of
ganglia were dissected from the epicardial ganglion plexus and dispersed by
trituration in a high glucose culture medium (DMEM), 10% fetal calf serum, 100
units/ml penicillin and 0.1 mg/ml streptomycin. The dissociated neurons were
then plated onto glass cover slips coated with poly-L-lysine, and incubated at 37
°C under a 95% air-5% CO2 atmosphere for 48-72 hours.

Electrical Recordings
Electrophysiological recording methods used were similar to those
previously described (Cuevas et al., 1997). Active membrane properties and
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voltage-activated K+ channel currents in ICG neurons were studied under
current-clamp and voltage-clamp mode, respectively, using the whole cell patchclamp technique. Electrical access was achieved through the use of the
amphotericin B perforated-patch method to preserve the intracellular integrity and
prevent the loss of cytoplasmic components and subsequent alteration of the
functional responses of these neurons (Cuevas and Adams, 1994). For
perforated-patch experiments, a stock solution of amphotericin B (60mg/ml) in
dimethyl sulfoxide (DMSO) was prepared and diluted in pipette solution
immediately prior to use to yield a final concentration of 198 µg/ml amphotericin
B in 0.33% DMSO. Final patch pipette resistance was 1.0-1.3 MΩ to permit
maximal electrical access under the present recording configuration. Action
potentials were elicited by depolarizing current pulses (+100 pA) in absence and
presence of sigma ligands. Currents through depolarization-activated K+
channels were elicited by step depolarizations from –90 mV to more positive
potentials (-50 to +70 mV). For experiments studying the effects of sigma
receptor activation on IM, cells were held at -30 mV to activate the channel and
repolarized to -60 mV to deactivate the channels. Membrane voltages and
currents were amplified using an Axopatch 200B patch-clamp amplifier (Axon
Instruments, Union City, CA), filtered at 5 kHz (-3 dB; 4-pole Bessel filter), and
digitized at 20 kHz (Digidata 1200 B).
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Data Analysis
Analyses of these data were conducted using the SigmaPlot 2000
program (SPSS Science, Chicago, IL). Data points represent means ± SEM.
Statistical difference was determined using paired t-test for within-group
experiments, and unpaired t-test for between groups experiments, and was
considered significant if p< 0.05.
Solutions and Reagents
The bath solution for action potential experiments was a physiological
saline solution (PSS) containing (in mM) 140 NaCl, 1.2 MgCl2, 3 KCl, 2.5 CaCl2,
7.7 glucose and 10 HEPES, pH to 7.2 with NaOH. Potassium channel currents
were isolated by adding tetrodotoxin (TTX, 400nM) and cadmium chloride
(CdCl2, 100 µM) to the PSS to inhibit voltage-activated Na+ channel and Ca2+
channel currents, respectively. Pipette solution used for perforated-patch
experiments contained (in mM): 75 K2SO4, 55 KCl, 5 MgSO4, and 10 HEPES
(adjust to pH 7.2 with N-methyld-glucamine). For studies using conventional
(dialyzing) whole cell recording configuration, the pipette solution contained (in
mM) 140 KCl, 2 MgCl2, 2 ethylene glycol-bis (ß-aminoethyl ether)N,N,N’,N’-tetraacetic acid (EGTA), 2 Mg2ATP, 0.1 GTP lithium salt (GTP), and
10 HEPES-KOH, pH to 7.2. In some experiments GTP was replaced with 100
µM guanosine 5’-O-(2-thiodiphosphate) trilithium salt (GDP-ß-S) to inhibit G
protein activation. All chemical reagents used were of analytical grade.
Haloperidol; ibogaine hydrochloride; (+)-pentazocine; 1,3-Di61

Otolylguanidine(DTG); 2S-(2a,6a,11R*]-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3(2-propenyl)-2,6-methano-3-benzazocin-8-ol hydrochloride ((+)-SKF 10,047);
tetrodotoxin (TTX);tetraethylammonium chloride (TEA) and linopirdine were
purchased from Sigma Chemical (St. Louis, MO).
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RESULTS

Sigma Receptors Activation Inhibit Delayed Outward Rectifying K+ Currents
Mammalian ICG neurons exhibit currents mediated by delayed outwardly
rectifying K+ channels (Xi-Moy and Dun, 1995; Hogg et al., 1999) and express
various subunits that contribute to these channels, including KCNA5 and KCNA6
(Cuevas, unpublished observation). Given that sigma-1 receptors have been
shown to depress heterologously expressed KCNA5 channels (Aydar et al.,
2002), and that inhibition of these channels may have significant effects on the
function of ICG neurons, it seemed prudent to test the effects of sigma receptor
activation on currents mediated by voltage-activated K+ channels in these cells.
Figure 1A shows a family of depolarization-activated K+ currents recorded from a
single ICG neuron in the absence and presence of DTG (100µM). Bath
application of 100 µM DTG depressed peak voltage-activated K+ current
amplitude at potentials positive to +20 mV. The voltage-dependence and kinetics
of the currents observed are consistent with the delayed outwardly rectifying K+
current (IK(DR)) previously reported in ICG neurons (Xi-Moy and Dun, 1995).
Figure 1B shows a plot of the mean peak IK(DR) amplitude in the absence and
presence of DTG as a function of voltage. The DTG-induced block of IK(DR) was
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voltage-dependent, with the current being blocked by 26.5 ± 6.2% at +70 mV, but
only by 1.5 ± 0.1% at +10 mV (n =7). This difference was statistically significant
(P < 0.01).

Concentration-Dependent Inhibition of IK(DR) by Sigma Ligands
Further pharmacological experiments were undertaken to confirm that
sigma receptors inhibit IK(DR) in ICG neurons and to identify the sigma receptor
subtype mediating the observed effects. Figure 2A shows representative
currents recorded from three ICG neurons in the absence (Control) and presence
of (+) pentazocine, ibogaine, and DTG, respectively, at the indicated
concentrations. All of the sigma ligands tested depressed peak IK(DR) in a
concentration dependent manner. A plot of the mean peak IK(DR) as a function of
drug concentration for several sigma ligands is shown in Figure 2B. Fits of the
data using the Hill equation gave half maximal inhibitory concentration (IC50)
values for haloperidol, (+)-pentazocine, ibogaine , (+)SKF10,047 and DTG of 9.7
± 0.5, 76.4 ± 7.7 µM, 218.1 ± 7.0 µM, 295.4 ± 45.4 µM and 341.3 ±
26.0 µM, respectively, and Hill coefficients of ~0.9 for all drugs. Maximum
inhibition of IK(DR) by sigma ligands was over 80%. The IC50 values and rankorder potency, in particular the observation that (+) pentazocine is significantly
more potent than ibogaine (p< 0.001) suggests that the effect on IK(DR) is
mediated by activation of sigma-1 receptors.
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The Sigma Receptor Antagonist, Metaphit, Depresses the Effect of DTG on
K+ Channels
To confirm the fact that the effect of sigma ligands on IK(DR) was mediated
by activation of sigma receptors and not the result of direct channel block,
experiments were done using the irreversible sigma receptor antagonist,
metaphit. Metaphit rapidly and specifically acetylates sigma receptors, and
inhibits ligand binding to the receptor (Bluth et al., 1989). In ICG neurons,
metaphit has been shown to block sigma-2 receptor mediated attenuation of
voltage-gated Ca2+ channel currents (Zhang & Cuevas, 2002). Isolated ICG
neurons were preincubated in 50 µM metaphit (in PSS) for 10 min at room
temperature. Following wash out of drug, IK(DR) was activated by depolarizing
cells to +50 mV from a holding potential of -90mV in the absence and presence
of 100 µM DTG. Figure 3A shows representative currents recorded from two
different ICG neurons without (upper) or with (lower) metaphit preincubation.
Upon application of DTG, IK(DR) peak amplitude was depressed under both
conditions, but in cells preincubated in metaphit the response to DTG was
obtunded. Figure 3B shows a bar graph of degree of block of IK(DR) by 100 µM
DTG in control neurons (DTG; n=4) or neurons
preincubated in metaphit (Metaphit + DTG; n=5). DTG decreased mean IK(DR) by
31 ± 3% control cells, whereas in cells exposed to metaphit the decrease was 18
± 3%. The difference in DTG attenuation of IK(DR) for the two conditions was
statistically significant (p<0.05). Several other sigma receptor antagonists
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including SM-21, BD-1047 and BD-1067 were tested to determine if these agents
could block the effects of DTG on IK(DR). However, all of these drugs themselves
depressed peak amplitude of IK(DR), suggesting that they are either acting as
partial agonists of the sigma-1 receptors, as reported previously for BD-1047
(Zambon et al., 1997), or having direct effects on the K+ channels.

Effect of Intracellular Dialysis with GTP and GDP-ß-S on Sigma Receptor
Inhibition of IK(DR)
Controversy exists in the literature as to whether sigma receptors couple
to G proteins and if these second messengers are involved in the regulation of
ion channels by sigma receptors. To determine if sigma receptor-mediated
inhibition of K+ channels in intrinsic cardiac neurons is dependent on G protein
activation, neurons were dialyzed with pipette solution containing either GTP
(100 µM) or the G protein inhibitor, GDP-ß-S (100 µM). Cell dialysis with 100 µM
GDP-ß-S has previously been shown to successfully block G protein mediated
signal transduction in intrinsic cardiac neurons (Cuevas and Adams, 1994, 1997;)
Figure 4A shows representative currents in response to step depolarizations from
-90 to +50 mV recorded from two neurons dialyzed with either GTP (top traces)
or GDP-ß-S (bottom traces) in the absence and presence of 100 µM DTG. The
inhibition of IK(DR) evoked by this concentration of DTG under dialyzing conditions,
with GTP in the pipette, was similar to that observed when the intracellular milieu
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was preserved (~30%). The DTG induced attenuation of IK(DR) was present when
the cells were dialyzed with GDP-β-S (Fig 4A, bottom terraces). A summary of
the peak IK(DR) amplitudes elicited upon depolarization to +50 mV under the
different experimental conditions and normalized to their respective control
values is presented in Figure 4B. The difference observed between the two
groups was not statistical significant. The I-V relationships for 6 neurons
dialyzed with either GTP or GDP-β-S are shown in Figure 4C and Figure 4D,
respectively. While dialyzing cells with GDP-β-S decreased the peak IK(DR)
amplitude, as compared with the cells dialyzed with GTP, DTG attenuated peak
amplitudes under both conditions to a similar extent. These data suggest that
neither cell dialysis nor inhibition of G-protein activation blocks sigma-1 receptormediated inhibition of IK(DR). Thus, neither a diffusible cytosolic second
messenger nor a G protein couples sigma-1 receptors to IK(DR).

Effects of Sigma Receptor Ligands on AP Firing
Studies have shown that inhibition of IK(DR) by verapamil in ICG neurons
can depress AP firing (Hogg et al., 1999). Experiments were thus conducted to
determine if sigma receptor modulation IK(DR) has a similar effect on
neuroexcitability in these cells. The effects of sigma ligands on the active
membrane properties of isolated ICG neurons were studied using the
amphotericin B perforated-patch method under current clamp mode. Figure 5A
shows a family of APs elicited from a single ICG neuron in response to
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depolarizing current pulses (100 pA; 300 ms) in the absence (control) and
presence of 100 µM DTG (DTG), and following washout of drug (wash). DTG
depolarized the neuron and decreased the number of APs evoked by the current
injection in a rapidly reversible manner. In similar experiments, 100 µM DTG
depolarized neurons from a control value of 50.8 ± 2.1 mV to -49.2 ± 2.4 mV (n
=9). DTG also decreased the number of APs evoked by depolarizing membrane
pulses by 85% (Figre 5B). Both of these changes were statistically significant
(p<0.01and p<0.001, respectively). DTG also altered the AP configuration by
decreasing both the AP overshoot and afterhyperpolarization, and by slowing
both the rate of depolarization and rate of repolarization (inset of figure 5A and
table1). The effects of DTG were mimicked by haloperidol (10 µM), ibogaine
(200 µM), and (+) pentazocine (50 µM), which depressed AP firing by 65%, 85%
and 65%, respectively and changed the configurations of the waveform in a
reversible manner. The effects of the sigma ligands on the AP firing and
configuration are summarized in Table1.

Role of M-Currents in the Effects of Sigma Receptor Activation.
One possible mechanism by which sigma-1 receptor activation
depolarizes ICG neurons is via a block of the M-current. Previous studies have
shown that inhibition of IM by muscarinic receptor activation depolarizes ICG
neurons (Cuevas et al., 1997). The M channels mediating IM are non-inactivating
and close slowly in response to membrane repolarization from depolarizing
68

holding potentials. The closing of these channels in ICG neurons upon
repolarization results in a characteristic inward current relaxation (Cuevas et al.,
1997). Figure 6A shows whole-cell currents recorded from a single cell in
response to repolarizing steps to -60 mV from a holding potential of -30 mV in the
absence (Control) and presence of 1 mM DTG. The inward relaxation observed
under control conditions is abolished by application of DTG. Similarly, linopirdine
(20 µM), a specific blocker of IM (Wallace et al., 2002), eliminates the inward
relaxation (Figure 6B). Figures 6C and 6D show bar graphs of mean peak IM
recorded under control conditions (absence of drug) and when either DTG (n = 4)
or linopirdine (n = 6) were added, respectively. IM was completely blocked by
application of either drug, and this effect was reversible after wash out in both
cases (data not shown).

Effects of Sigma Receptor Activation on BK Currents
In central and peripheral neurons, AP afterhyperpolarizations (AHP) are
mediated by the opening of Ca2+-activated K+ channels (IK(Ca)). Thus far, three
types of Ca2+- activated K+ channels have been identified on the basis of their
pharmacology and single channel conductances. These channels have been
named according to their unitary conductance: large (big) conductance K(Ca)
channels (BK), small conductance K(Ca) channels (SK) and intermediate
conductance (IK). While both BK and SK channels have been found in
mammalian ICG neurons, neonatal rat ICG neurons only express BK channels
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(Franciolini et al., 2001; Jelson et al., 2003). The fact that sigma receptor
activation decreases the AHP suggests that sigma receptors may modulate
these channels. TEA, at micromolar concentrations (200-500 µM), has been
shown to preferentially block BK channels in ICG neurons and to block the AHP
more effectively than either charybdotoxin or iberiotoxin (Franciolini et al., 2001).
Thus, 500 µM TEA was used to distinguish between outward K+ currents
mediated by BK and other K+ channel types (i.e. IK(DR), IM). Outward currents
were evoked by stepping to +50 mV from a -90 mV holding potential in the
absence and presence of 500 µM TEA. The net TEA-sensitive current, and thus
the current mediated by BK channels, was determined by subtracting the current
remaining after TEA application from that observed under control conditions
(absence of TEA). Two distinct TEA-sensitive currents, which differed in their
time-dependent inactivation kinetics, were seen in our experiments. These
currents were expressed in different populations of neurons, with the fast
inactivating current (BKi) being expressed in 6 of 10 cells and the slowlyinactivating or noninactivating currents (BKs) being expressed in the remaining 4
cells. Currents representative of each BK channel subtype are shown in Figures
7A and 7B. Both the rapidly decaying and the slowly decaying TEA-sensitive
currents were blocked by 1 mM DTG. Figure 7C and 7D show bar graphs of the
mean peak and sustained current amplitude obtained from the BKi (n = 6) and
BKs (n = 4) species, respectively. Both phases of the current were reduced in the
two current types when 1 mM of DTG was applied.
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Figure 3.1 Sigma receptor ligands inhibit IK(DR) in rat ICG neurons. A:
Depolarization activated (-50 to +70 mV; 300 ms) K+ currents recorded from a
single neuron held at -90 mV in the absence (Control) and presence of 100 µM
DTG (DTG) or after washout of drug (Wash). B: Peak IK(DR) current density as a
function of voltage recorded in a similar manner from 7 neurons in the absence
(o) and presence (●) of 100 µM DTG.
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Figure 3.2. Dose-dependent inhibition of IK(DR) by sigma receptor ligands in rat
ICG neurons. A: Whole-cell K+ currents evoked from 3 ICG neuron by step
depolarizations to +50 mV from a holding potential of -90 mV in the absence
(Control) and presence of (+) pentazocine, ibogaine, and DTG at the indicated
concentrations. B: Peak whole-cell IK(DR) current amplitude, evoked by
depolarizing to +50 mV from -90 mV, normalized to control and plotted as a
function of sigma ligands concentration. Data points represent mean ± SEM for
≥4 observations. The curves represent best fit to the data using the Hill equation.
Half-maximal inhibition was 9.7 ± 0.5 µM for haloperidol, 76.4 ± 7.7 µM for (+)pentazocine, 218.1 ± 7.0 µM for ibogaine, 295.4 ± 45.4 µM for SKF10,047 and
341.3 ± 26.0 µM for DTG. The corresponding Hill coefficients were 1.01 ± 0.05,
0.69 ± 0.05, 1.14 ± 0.04, 0.84 ± 0.11, 0.97 ± 0.07, respectively.
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Figure 3.3 Attenuation of DTG-mediated inhibition of IK(DR) by the sigma receptor
antagonist, metaphit. A: depolarization-activated (-90 to 50mV) IK(DR) recorded
from 2 ICG neurons in the absence (Control) and presence of 100µM DTG
(DTG). Bottom traces are from a neuron preincubated in metaphit (50 µM in
PSS, 10 min). B: bar graph of the percent inhibition of mean peak IK(DR) (± SE)
produced by 100 µM DTG in control cells that were not exposed to metaphit
(DTG) or cells preincubated in metaphit (50 µM, 10 min; Metaphit + DTG). IK(DR)
was evoked by step depolarizations (-90 to +50 mV). Data were collected from 7
neurons for each condition, and asterisk denotes significant difference between
the groups (p<0.05)
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Figure 3.4 Sigma receptor inhibition of IK(DR) is not blocked by intracellular GDPß-S. A: Depolarization activate (-90 to +50 mV) K+ currents recorded from
neurons dialyzed with pipette solutions containing either 100 µM GTP or GDP-ßS in the absence (Control) or presence of 100 µM of DTG (DTG). B: Mean (±
SEM) peak Ik(DR) recorded from neurons dialyzed with either GTP (n=6) or GDPß-S (n=6) in the presence of 100 µM DTG. Currents are normalized to their
respective controls (absence of drug). Mean (± SE) peak Ik(DR) current density as
a function of depolarization voltage (-90 mV, holding potential) recorded from
neurons dialyzed with pipette solution containing either 100 µM GTP (C, n = 6) or
100 µM GDP-ß-S (D, n = 6) in the absence (o) and presence (●) of 100 µM DTG.
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Figure 3.5 Inhibition of AP firing by sigma receptor ligand, DTG, in rat ICG
neurons. A: APs fired from an isolated ICG neuron in response to 100 pA
depolarizing current pulses in the absence (Control) and presence of 50 µM DTG
(DTG), and following washout of drug (Wash). Inset is superimposition of first AP
from Control and DTG traces. B: Bar graph of the number of APs fired in the
absence (Control) or presence of 100 µM DTG (DTG) and following washout of
the drug (Wash). Asterisk denotes significant difference from Control and DTG
(p<0.01) (n=7).
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Figure 3.6 The sigma receptor ligand, DTG, inhibits the M-current in rat ICG
neurons. A: Slow inward current relaxation (M-current) induced by repolarizing
step (-30 mV to -60 mV,250 ms) recorded from a single ICG neuron before
(Control) and after application of 1mM of DTG (DTG). B: M-current recorded in
the absence (Control) and in the presence of 20 µM linopirdine (Linopirdine). Bar
graph of mean current amplitudes in the absence (Control) or presence of 1mM
DTG (C, n = 4) and 20 µM linopirdine (D, n= 6). The amplitude of the M current
was defined as the difference between the peak current observed at the start of
the relaxation (panel A, left trace, black arrow) and the holding current at the end
of the 250 ms repolarizing step (panel A, left trace, gray arrow). Asterisks denote
significant difference from Control (p<0.001).
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Figure 3.7 Sigma receptor activation blocks large conductance Ca2+-activated K+
channel (BK) in rat ICG neurons. Traces of BK mediated currents recorded from
two neurons, expressing fast inactivating (A) and slowly-inactivating BK channels
(B), in the absence (Control) and presence of 1 mM DTG (DTG). BK mediated
currents were evoked by step depolarizations to +50 mV from a holding potential
of –90 mV, and defined as the net TEA sensitive current. The net TEA-sensitive
current was determined by subtracting the outward current recorded in the
presence of 500 µM TEA (with or without DTG) from the outward current
obtained in the absence of TEA (with or without DTG). Bar graph of the peak
and sustained BK current amplitudes recorded in the absence (Control) and
presence of DTG (DTG, 1mM) in cells expressing fast-inactivating (C, n = 6) or
slowly-inactivating (D, n = 4) BK channels. Asterisks denote significant
difference from control (p<0.05).
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RMP (mV)
Control

-50.8 ± 2.1

Peak Amplitude
(mV)
34.4 ± 5.7

Rising Slope
(mV/sec)
55.9 ± 19.9

Decay Slope
(mV/sec)
-30.4 ± 5.9

After
Hyperpolarization(mV)
-21.7 ± 1.3

DTG (100µM)

-49.2 ± 2.4*

4.6 ± 5.6**

11.8 ± 6.3**

-8.6 ± 3.6**

-12.3 ± 2.1**

Control

-51.0 ± 2.1

25.1 ± 5.2

36.4 ± 8.1

-20.3 ± 2.9

-22.2 ± 2.2

PTZ (50µM)

-48.9 ± 2.3*

11.7 ± 4.9**

12.7 ± 4.0*

-7.6 ± 1.7**

-16.6 ± 1.6**

Control

-54.5 ± 1.3

35.9 ± 3.5

59.4 ± 6.0

-26.7 ± 2.7

-22.8 ± 1.1

IBO(200µM)

-51.0 ± 2.2*

-3.9 ± 6.3**

4.7 ± 1.7**

-4.7 ± 1.6**

-6.3 ± 2.7**

Table 3.1 Effects of sigma ligands on the resting membrane potential and AP waveform parameters. APs were evoked
by 100 pA current injections. All drugs were bath applied and the data are shown as: mean ± SE (n=5-6). Asterisks
denote significant difference. (*: p<0.05 and **: p<0.01).
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DISCUSSION

The results presented here show that in neonatal rat ICG neurons
activation of sigma-1 receptors reversibly inhibited IK(DR), IK(Ca) and IM through a
pathway that involved neither a diffusible cytosolic second messenger nor a Gprotein. Furthermore, activation of sigma receptors resulted in the depolarization
of the neurons and depression of neuroexcitability. It has been shown that
sigma-1 receptors are expressed in parasympathetic ICG neurons, but the
cellular function of these receptors remained unknown. Whereas sigma-2
receptors in these cells couple to Ca2+ channels, sigma-1 receptors modulate the
function of various K+ channels in these neurons. While the modulation of Ca2+
channels in ICG neurons by neurotransmitters is well documented, less is known
about the regulation of K+ channels in these cells (Adams and Cuevas, 2004).
Activation of M1 muscarinic receptors in neonatal rat ICG neurons has been
shown to block IM in these cells (Cuevas et al., 1997), and activation of a PGE2
receptor inhibits a small-conductance IK(Ca) in adult guinea pig ICG neurons
(Jelson et al., 2003). Sigma-1 receptor activation, however, inhibits multiple K+
channels subtypes in ICG neurons. The modulation of K+ channels by sigma
receptors has been reported in mouse sympathetic neurons, frog melanotrophs,
and mouse neurohypophysial nerve terminals (Kennedy and Henderson, 1990;
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Soriani et al., 1998; Soriani et al.,1999a&b; Wilke et al.,1999). The K+ channel
types that have been shown to be modulated by sigma receptor activation
include A-Type K+ channels (IA), IK(Ca), IK(DR), and IM, and multiple K+ channels
types are frequently affected in individual cells (Soriani et al.,1999a, Wilke et
al.,1999a, Soriani et al.,1999b). All of those K+ channel subtypes, except A-Type
K+ channels which are not expressed in ICG neurons, were shown to be affected
by sigma receptor activation in our study. While sigma receptors have been
shown to block K+ channels in native cells, the sigma receptor subtype mediating
these effects has not been definitively identified. The rank order potency for IK
inhibition by sigma ligands reported here, haloperidol > (+)-pentazocine >
ibogaine > DTG, suggests that the effect is mediated by sigma-1 receptor
activation. In contrast, the rank order potency for sigma ligand inhibition of Ca2+
channels in ICG neurons is: haloperidol > ibogaine > (+)-pentazocine > DTG,
which is consistent with a sigma-2 receptor mediated effect. The IC50 values for
the various sigma ligands tested here are in agreement with those reported in the
literature for modulations of voltage-gated K+ channels. For example, in frog
pituitary melanotrophs, (+)-pentazocine inhibited delayed outwardly rectifying K+
channels with an IC50 of 37 µM , compared to the IC50 of 42 µM reported here.
Similarly, 100 µM (+)-SKF10047 blocked approximately 50% of the voltageactivated K+ currents recorded in neurohypophysial nerve terminals (Wilke et al.,
1999a). Thus, sigma-1 receptors are likely to be responsible for inhibition of K+
channels in ICG neurons and in other native cells studied. The conclusion that
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sigma receptors mediate the inhibition of IK by sigma ligands in ICG neurons is
strengthened by the observation that metaphit, an irreversible, antagonist of
sigma receptors, blocks the effects of DTG on IK in these cells. Considerable
controversy exists as to the mechanisms by which sigma receptors modulate K+
channels. In frog pituitary melanotrophs, cell dialysis with GTP-β-S and
preincubation in cholera toxin were shown to inhibit sigma receptor effects on IA
and IK(DR) (Soriani et al., 1999 a&b), suggesting that sigma receptors couple to
the K+ channels via a G protein. G proteins have also been implicated in both
sigma receptor-mediated activation of phospholipase C and regulation of Ca2+
release from intracellular stores (Morin-Surun et al., 1999; Hayashi et al., 2000).
However, neither cell dialysis nor application of intracellular GTP-β-S blocked the
inhibition of IK by sigma-1 receptors in ICG neurons. Thus, sigma receptors
couple to K+ channels in these cells via a membrane-delimited signal
transduction cascade that does not involve a G protein. Our observation is in
agreement with the direct protein-protein interaction between Sigma-1 receptors
and K+ channels shown by Jackson and colleagues (Lupardus et al., 2000; Aydar
et al., 2002). The net effect of sigma receptor modulation of ion channels in ICG
neurons at rest is depolarization of the membrane potential. We have previously
shown that the IM contributes to the resting membrane potential of ICG neurons
and that inhibition of this channel depolarizes the cells (Cuevas et al., 1997).
Given that application of DTG blocks IM, sigma receptor modulation of these
channels likely accounts for the depolarizations reported here. Further support
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for this conclusion comes from the fact that neither inhibition IK(DR) nor IK(Ca) has
been linked to changes in the resting membrane potential of these neurons
(Hogg et al., 1999; Xu and Adams, 1992; Jelson et al., 2003). Inhibition of
voltage gated Ca2+ channels by sigma-2 receptor activation is also unlikely to
account for this depolarization since removal of extracellular Ca2+ does not alter
the resting membrane potential of these cells (DeHaven and Cuevas, 2004). The
block of IK by sigma receptors in ICG neuron is associated with decreased AP
firing, whereas previous studies have shown that sigma receptor block of IK
enhances neuroexcitability (Soriani et al., 1998). Our laboratory has shown that
inhibition of IM is associated with increased excitability of ICG neurons (Cuevas et
al., 1997), and thus sigma receptor modulation of non-IM K+ channels must be
responsible for the decreased excitability observed. The depressed
neuroexcitability reported here likely results from modulation of IK(DR) by sigma
receptors. Verapamil has been shown to convert tonic and adapting ICG
neurons into phasic neurons via a direct block of IK(DR) (Hogg et al., 1999).
However, high concentrations of verapamil failed to abolish AP firing in ICG
neurons, whereas high concentrations of sigma ligands completely blocked the
genesis of APs in these cells. The concentrations of (+) pentazocine (50 µM)
and ibogaine (200 µM) required to appreciably decrease AP firing and alter the
AP configuration in our study suggest that the effects of sigma ligands on the
active membrane properties of these cells are primarily mediated by sigma-1
receptors. However, inhibition of voltage-activated K+ channels alone cannot
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explain the complete block of AP firing at high concentrations of sigma ligands,
and thus sigma receptors are likely to affect other channel types that regulate AP
firing (e.g.voltage-gated sodium channels). The inhibition of IK(Ca) by sigma
receptors is also likely to contribute to changes in the active membrane
properties of ICG neurons. Two types of sigma receptor-regulated BK currents
were found in rat ICG neurons, one which exhibited rapid time-dependent
inactivation, BKi, and a second which showed little or no inactivation, BKs. The
presence of distinct subpopulations of BK channels with dissimilar inactivation
kinetics has been reported in rat adrenal chromaffin cells and mouse neocortical
pyramidal neurons and (Solaro et al., 1995; Sun et al., 2003). The inhibition of
BK currents by sigma receptors would account, at least in part, for the increase in
AP duration and decrease in AHP reported here, since inhibition of BK by 200
µM TEA produces similar effects on the APs of these cells (Franciolini et al.,
2001). While inhibition of voltage-gated Ca2+ channels may contribute to the
decrease in IK(Ca) amplitude observed in our studies, it is unlikely to exclusively
account for the block of BK channels observed here. Evidence for this
conclusion comes from the fact that concentrations of Cd2+ (100 µM) that inhibit
all Ca2+ channels in these neurons (Cuevas and Adams, 1997) fail to eliminate
the AHP in these cells (Franciolini et al., 2001). Furthermore, in our study, 100
µM Cd2+ blocked < 5% of IK, whereas 500 µM TEA or Ca2+-free extracellular
solution blocked ~25% of IK (data not shown). Taken together, these data
suggest that sigma-1 receptors are likely having a direct effect on BK channels in
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ICG neurons. However, sigma receptor modulation of other mechanisms of Ca2+
entry or homeostasis must also be examined to confirm a direct effect on IK(Ca).
There has been considerable speculation about the role of sigma receptors in the
cardiovascular system. While the endogenous ligand responsible for activating
sigma receptors under physiological and pathophysiological conditions remains
to be determined, there is data suggesting that some putative sigma receptor
ligands may affect the heart and coronary vasculature. For example,
pregnenolone, a putative sigma ligand (Maurice et al., 2001), increases heart rate
and cardiac output in anesthetized dogs (Hogskilde et al., 1991). Such effects
may in part be due to activation of sigma receptors on ICG neurons. Similarly,
various drugs that act on sigma receptors, such as haloperidol, have significant
effects on the heart (Monassier and Bousquet, 2002). Our observations raise the
possibility that the cardiovascular effects of these compounds may be mediated
by their modulation of the electrical activity of intrinsic cardiac neurons. In
conclusion, stimulation of sigma-1 receptors inhibits multiple voltage-gated K+
channel subtypes and depresses excitability in ICG neurons. Thus, activation of
sigma-1 receptors in these cells is likely to attenuate parasympathetic input to the
heart and, consequently, affect cardiovascular function.
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CHAPTER 4
SIGMA RECEPTORS ACTIVATION INHIBIT VOLTAGE-GATED SODIUM
CHANNELS IN RAT ICG NEURONS

INTRODUCTION

Sigma receptors have been shown to modulate a variety of cell membrane
ion channels, including voltage-gated K+ ( Kennedy and Henderson, 1990;
Soriani et al., 1998; Wilke et al., 1999; Zhang and Cuevas, 2005) and Ca2+
channels (Soriani et al., 1999b; Zhang and Cuevas, 2002). The effects of sigma
receptors on voltage-gated Na+ channels, which play very important role in
cellular functions of central and peripheral neurons, as well as muscle cells, have
never been studied. We have shown that sigma receptors activation not only
inhibits the action potential (AP) firing but also decreases the amplitude of AP
overshoot (Zhang and Cuevas, 2005). Inhibition of K+ currents alone cannot
explain these effects, which suggests other channels are involved and Na+
channels could be one of them.
.

Voltage-gated Na+ channels are responsible for the initiation and

propagation of APs in both nerve and muscle cells (Hille 2001). Modulation of
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Na+ channels will influence the threshold of AP generation, as well as the
frequency of AP firing. So voltage-gated Na+ channels are primary targets for the
antiepileptic drugs and are used for identification and development of new
anticonvulsants (Ragsdale and Avoli, 1998; Chao and Alzheimer, 1995; Taylor
and Narasimhan, 1997). In addition to the antiepileptic action of voltage-gated
Na+ channels blockers, some other Na+ channel blockers are also used in the
treatments of neuropathic pain (Deffois et al., 1996), arrhythmia (Catterall 1981),
head trauma and stroke (Baumgold and Spector 1987; Meldrum 1994; Taylor
and Narasimhan 1997).
Voltage-gated Na+ channels also play important roles in cardiac functions
and the modulators of voltage-gated Na+ channels have been shown enormous
potential for therapeutic advances in the treatment of heart failure (Doggrell et al.,
1994; Doggrell and Liang, 1998). Mammalian intracardiac ganglia (ICG) are
thought to exert local regulation over cardiac function by integrating information
from efferent and afferent pathways of both parasympathetic and sympathetic
origin (Moravec and Moravec, 1987) and the ICG neurons express similar types
of Na+ channels as CNS. So investigating the effects of sigma receptors on
voltage-gated Na+ channels in ICG neurons will help understanding the cellular
effects of these receptors, as well as providing more information on the
mechanisms of the effects of these receptors, especially in the cardiovascular
system.
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Experiments were undertaken to determine the effects of sigma receptors
on voltage-gated Na+ channels and the AP firing latency of ICG neurons from
neonatal rats. The sigma ligands used here include: DTG, ibogaine, (+)
pentazocine and BD1047. These compounds have been selected because they
are structurally dissimilar, which will help to rule out other nonspecific effects, for
example, direct binding to Na+ channels or through other receptors. Also these
compounds have different selectivies for two subtypes of sigma receptors, which
will help to differentiate the receptor subtype that mediates the modulations of
Na+ channels. Sigma receptor ligands were shown to have inhibitory effects on
the current mediated by voltage-gated Na+ channels (INa) and shifted the steadystate inactivation of Na+ channels to more negative potentials. Activation of
sigma receptors also increased the latency of AP generation produced by
depolarizing current ramps.
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METHODS

Preparation of Cell Culture
The isolation and culture of neurons from neonatal rat ICG ganglia has
been described previously (Cuevas and Adams, 1994). Dissociated neurons
were plated onto poly-L-lysine coated glass coverslips and incubated at 37°C for
36-72 hr under a 95% air, 5% CO2 environment prior to the experiments.

Electrical Recordings
Electrophysiological recording methods used were similar to those
previously described (Cuevas et al., 1997). Voltage-activated Na+ channel
currents in ICG neurons were studied by using the whole cell patch-clamp
technique under voltage-clamp mode. The conventional (dialyzing) whole cell
recording technique was used in the experiments studying current-voltage
relationship, while the amphotericin B perforated-patch method was used in other
experiments. For perforated-patch experiments, a stock solution of amphotericin
B (60mg/ml) in dimethyl sulfoxide (DMSO) was prepared and diluted in pipette
solution immediately prior to use to yield a final concentration of 198 µg/ml
amphotericin B in 0.33% DMSO. Final patch pipette resistance was 1.0-1.3 MΩ
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to permit maximal electrical access under the present recording configuration.
Currents through depolarization-activated Na+ channels were elicited by step
depolarizations from –90 mV to more positive potentials (-50 to +100 mV). For
experiments studying the effects of sigma receptor on steady state inactivation of
Na+ channel, cells were prepulsed to different voltage (-120 mV to 0 mV) from
holding potential of -90 mV and then depolarized to 0 mV to activate the channel.
AP was evoked by current ramp (0 to 200 nA, 400 ms) and the latency of AP
generation was determined as the time interval from onset of the current ramp to
the point at which the rising phase of the AP crossed 0 mV. Membrane voltages
and currents were amplified using an Axopatch 200B patch-clamp amplifier
(Axon Instruments, Union City, CA), filtered at 5 kHz (-3 dB; 4-pole Bessel filter),
and digitized at 20 kHz (Digidata 1200 B).

Solutions and Reagents
The bath solution used in Na+ channel experiments was a physiological saline
solution (PSS) composed of (in mM):70 NaCl, 70 tetraethylammonium chloride
(TEA), 5 BaCl2, 1.2 MgCl2, 7.7 glucose, 0.1 cadmium chloride (CdCl2), and 10
HEPES (pH to 7.2 with NaOH). Barium and TEA were used to block voltagegated K+ channels and cadmium was used to block voltage-gated Ca2+ channels.
Pipette solution used for Na+ channel experiments contained (in mM): 130 CsCl,
10 NaCl, and 10 HEPES (adjust to pH 7.2 with CsOH). The bath solution for AP
experiments was a physiological saline solution (PSS) containing (in mM) 140
93

NaCl, 1.2 MgCl2, 3 KCl, 2.5 CaCl2, 7.7 glucose and 10 HEPES, pH to 7.2 with
NaOH. Pipette solution used for AP experiments contained (in mM): 75 K2SO4,
55 KCl, 5 MgSO4, and 10 HEPES (adjust to pH 7.2 with N-methyld-glucamine).
All chemical reagents used were of analytical grade. Ibogaine hydrochloride; (+)pentazocine; 1,3-Di-Otolylguanidine(DTG); BD1047, and tetraethylammonium
chloride (TEA) were purchased from Sigma Chemical (St. Louis, MO).

Data Analysis
Analyses of these data were conducted using the SigmaPlot 2000
program (SPSS Science, Chicago, IL). Data points represent means ± SEM.
Statistical difference was determined using paired t-test, and was considered
significant if p< 0.05.
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RESULTS

Sigma Receptor Activation Inhibits Voltage-Gated Na+ Channel Currents.
Sigma receptors have been shown to inhibit AP firing and decrease AP
overshot. One of the mechanisms by which sigma receptors may modulate AP
firing is through inhibition of voltage-gated Na+ channels. Voltage-gated Na+
channel currents were isolated by inhibiting Ca2+ currents with extracellular Cd2+,
and K+ currents with extracellular TEA and intracellular Cs+. Figure 1A shows a
family of depolarization-activated Na+ currents recorded from a single ICG
neuron in the absence and presence of 100 µM ibogaine. Under control
conditions, INa was activated at approximately -30mV and the I-V relation was
maximal at -10 mV, reversing at approximately +70 mV. The voltage
dependence and kinetics of the currents observed are consistent with voltagegated Na+ channel currents characterized in ICG neurons (Xu and Adams, 1992).
Bath application of 100 µM of ibogaine depressed the peak INa at potentials
positive to -20 mV and shifted the reversing potential from +70 mV to +50 mV.
Sigma-1 receptor agonist, pentazocine, at 100 µM concentration, had similar
effects (data not shown).
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Concentration-dependent Inhibition of INa by Sigma Ligands
Further pharmacological experiments were undertaken to confirm that
sigma receptor activation mediated the inhibitory effects of INa of sigma ligands
and to identify the sigma receptor subtype mediating the observed effects.
Figure 2A shows representative currents recorded from single ICG neuron in the
absence (control) and presence of (+)-pentazocine (PTZ), at the indicated
concentration. A plot of the mean peak INa as a function of drug concentration for
several sigma ligands is shown in Figure 2B. All of the sigma ligands tested
depressed peak INa in a concentration-dependent manner. Fits of the data using
the Hill equation gave half-maximal inhibitory concentration (IC50) values for
DTG, ibogaine and pentazocine of 30.0 µM, 30.9 µM and 50.8 µM, respectively,
and Hill coefficients of ~1.0 for all drugs. Maximal inhibition of INa was more than
90%.
BD 1047 was claimed as sigma-1 receptor antagonist (Matsumoto et al.,
1995 ), however, it was also reported as partial agonist of sigma receptors
(Zambon et al., 1997). In our system, we have shown that BD1047 had similar
effects as sigma receptors agonist as to block K+ channel currents (data not
shown). Effects of BD1047 on voltage-gated Na+ channels are shown in Figure
3. Figure 3A shows representative currents recorded from single neuron in the
absence and presence of different concentrations of BD1047, as indicated.
Similar as sigma receptor agonists, BD1047 dose-dependently depressed INa and
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the IC50 value for BD1047 was 54.8 µM, which suggests it is either a partial
agonist of the sigma receptors or has direct effects on the Na+ channels.
The effect of sigma ligands on INa amplitude was reversible on wash out.
Figure 4A shows a family of Na+ currents evoked by step depolarization from a
single neuron in the absence (control), presence (+DTG), and following wash out
of the sigma ligand, DTG (wash). Following inhibition of INa, the current
recovered gradually and similar reversal of inhibition was observed for all sigma
ligands tested here (data not shown).

Effects of Sigma Receptors Activation on Voltage-gated Na+ Channel
Inactivation
The effects of DTG (30 µM) on steady-state inactivation of Na+ channels in
rat ICG neurons was studied using a double pulse protocol. Neurons were
initially held at -90 mV, and 50 ms prepulses from -120 to 0 mV were applied in
10 mV increments prior to a voltage step to 0mV (50 ms) to activate the available
Na+ channels. A plot of the relative peak current amplitude (I/Imax) as a function
of prepulse voltage is shown in Figure 5. The steady-state inactivation of INa
exhibited a sigmoidal dependence on voltage and was best fit with a single
Boltzmann function according to the equation
INa = INa(max)/{1 + exp{(V-Vh)/k]}
In the absence of DTG, a fit of the mean relative I-V relationship exhibited halfmaximal steady-state inactivation (Vh) at -50 mV and had a slope parameter (k)
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of 7.5. While in the presence of DTG, a fit of mean relative I-V relationship
exhibited Vh at -64 mV and k of 15.

Effects of Sigma Receptors on the Latency of AP Generation
One of the important functions of voltage-gated Na+ channel is the
initiation and propagation of AP. Effects of sigma ligands on the latency of AP
generation were tested during a 400 ms depolarizing current ramp by using the
perforated patch whole cell recording configuration under current clamp mode.
Figure 6A shows a family of AP in response to depolarizing current ramp in the
absence and presence of 30 µM of DTG. The latency of AP determined as the
time interval from onset of the current ramp to the point at which the rising phase
of the AP crossed 0 mV (Parson et al., 2002) was significantly increased by DTG
(~35%). DTG also decreased the AP firing, as well as altered AP configuration
as reported before (Zhang and Cuevas, 2005). The effects of DTG were
mimicked by 50 µM of ibogaine, (+)-pentazocine and BD1047, which increased
the latency of AP firing by 15%, 20% and 15% respectively and the effects of all
sigma ligands are reversible after wash out of the drug (data not shown).
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Figure 4.1 Inhibition of Na+ channel currents in rat ICG neurons by the sigma
receptor agonist, DTG. A: Whole-cell, Na+ currents evoked by depolarizing test
pulses (-50 to +100 mV) from a holding potential of -90 mV in the absence
(Control) or presence of 100 µM ibogaine (Ibogaine). B: Whole cell currentvoltage relation obtained in the absence and presence of 100 µM DTG. C:
Whole cell current-voltage relation obtained in the absence and presence of 100
µM ibogaine. Data points represent means ± SE for 3-4 cells..
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Figure 4.2 Dose-dependant inhibitions of depolarization-activated Na+ channel
currents by sigma receptors agonists in rat ICG neurons. A: Whole cell Na+
currents evoked from a ICG neuron by step depolarizations to -10 mV from a
holding potential of -90 mV in the absence (Control) and presence of (+)pentazocine (PTZ) at the indicated concentration. B: Peak whole cell INa
amplitude, evoked by depolarizing to -10 mV from -90 mV, normalized to control
and plotted as a function of sigma receptors agonists, (+)-pentazocine (PTZ),
ibogaine (IBO) and DTG, concentrations. Data points represent mean ± SE for 45 neurons. The curves represent best fit to the data using the Hill equation.
Half-maximal inhibition was 50.8 µM for (+)-pentazocine, 30.9 µM for ibogaine
and 30.0 µM for DTG and the hill coefficient was 1.0 for all compounds.
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Figure 4.3 Dose-dependant inhibitions of depolarization-activated Na+ channel
currents by sigma receptors antagonist or partial agonist, BD1047 in rat ICG
neurons. A: Whole cell Na+ currents evoked from a ICG neuron by step
depolarizations to -10 mV from a holding potential of -90 mV in the absence
(Control) and presence of BD1047(BD1047) at the indicated concentration. B:
Peak whole cell INa amplitude, evoked by depolarizing to -10 mV from -90 mV,
normalized to control and plotted as a function of concentration of BD1047. Data
points represent mean ± SE for 4 neurons. The curves represent best fit to the
data using the Hill equation. Half-maximal inhibition was 54.8 µM and the hill
coefficient was 1.0.
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Figure 4.4 Reversibility of DTG-induced block of voltage-gated Na+ channels. A:
Family of depolarization-activated Na+ channel currents recorded from a single
ICG neurons in the absence (Control) and presence of bath-applied 300 µM DTG
(+DTG), and following wash out of drug (Wash). B: Peak Na+ channel current
amplitude before and during application of 300 µM DTG and after removal of
DTG for the cell in A. Values are plotted as a function of time. Gap represents
period during which lower concentrations of DTG were applied, with 300 µM DTG
application commencing at t=20 min.
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Figure 4.5 Sigma receptor modulation of steady-state inactivation of Na+
channels in rat ICG neurons. Relative Na+ current amplitude as a function of
prepulse amplitude in the absence (control) and presence of 30 µM DTG (DTG).
Data points represent means ± SE for 7 neurons. Solid lines represent best fit to
the data with a single component Boltzmann distribution.
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Figure 4.6 Sigma receptors ligands increased the latency of AP generation in rat
ICG neurons. A: Example recording of AP generated by a 400 ms depolarizing
current ramp from one neuron prior to (solid line) and during DTG (30 µM) (dash
line) treatment. B: Bar graphs summarized the AP latency for multiple neurons
before (Control) and after application of sigma receptors ligands as indicated.
The concentrations for sigma ligands are: 30 µM of DTG, and 50 µM for
pentazocine (PTZ), ibogaine (IBO) and BD 1047. Asterisks indicated a
significant difference between conditions using a paired t-test. (*: p<0.05, **:
p<0.01)
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DISCUSSION

The results presented in this chapter provide the first evidence of
modulation of voltage-gated Na+ channels by sigma receptor ligands. Sigma
ligands dose-dependently inhibited INa in a reversible manner and shifted the
steady-state inactivation to more negative potentials. Furthermore, activation of
sigma receptors increased the latency of AP generation.
It has been shown in ICG neurons that sigma receptor ligands inhibit
voltage-gated K+ and Ca2+ channels through sigma-1 and sigma-2 receptor
activation, respectively. Previous experiments also showed that sigma receptor
ligands, at high concentration, abolish AP firing in these neurons. Although the
inhibition of K+ and Ca2+ channel currents contribute to the effects on AP firing, it
can not explain the significant decrease in the amplitude of the first AP overshoot
and complete block of AP firing at higher concentrations. Another possible target
of modulation by sigma receptors is voltage-gated Na+ channels, which are
responsible for the generation and conduction of AP in neurons. Like rat
sympathetic neurons, voltage-gated Na+ channels in rat intracardic neurons are
TTX sensitive, with complete blockade at 300 nM TTX (Xu and Adams, 1992).
The data presented here show that sigma ligands inhibit the voltage-gated Na+
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channels in a voltage-dependent manner. A shift in the reversal potential of Na+
channel to less positive potentials was also observed. One reason for this shift is
incomplete blockade of outward K+ currents by TEA (extracellular) and Cs2+
(intracellular). Compared with Na+ channel inhibition, both DTG and ibogaine
have less potency for blocking K+ channels and at 100 µm of concentration, they
only block about 20% of total outward K+ currents (Zhang and Cuevas, 2005).
So the outward current seen at +70 mV in the presence of DTG and ibogaine is
an artifact due to K+ current contamination. In contrast, pentazocine, which has
similar potency of blocking Na+ and K+ channels, does not shift the reversal
potential of Na+ channels (data not shown). The similar IC50 values of blocking
Na+ and Ca2+ channels of selective sigma-1 and sigma-2 receptor ligands, (+)
pentazocine (51 µM compared with 61 µM) and ibogaine (31 µM compared with
31 µM) suggest that like blocking of voltage-gated Ca2+ channels, sigma ligands
inhibit the voltage-gated Na+ channels also through sigma-2 receptor activation.
However this cannot explain the high potency of DTG which has equal affinity for
sigma-1 and sigma-2 receptors of blocking Na+ channels (IC50= 30 µM),
compared with Ca2+ (133 µM) and K+ channels (341 µM) inhibition. One
possibility is that DTG has direct effect on voltage-gated Na+ channels. This is
consistent with our observations that the inhibitory effect of DTG on Na+ channels
is not inhibited by the sigma receptor antagonist, metaphit (data not shown)
which blocked the inhibitory effects of DTG on voltage-gated Ca2+ and K+
channels (Zhang and Cuevas, 2002; Zhang and Cuevas, 2005).
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Voltage-gated Na+ channels are known to undergo two distinct inactivation
processes, a fast and a slow inactivation process, which occur within a few
milliseconds and a few seconds, respectively. In ICG neurons, the fast
inactivation process, which is mainly involved in the current shape and the
INamax (Ruff et al., 1996), was determined by double-pulse protocol in our
experiments. Our results show that DTG shift the steady-state inactivation to
more negative potentials. This effect is also seen as other sigma ligands (data
not shown). Thus the shifting of the steady-state inactivation of Na+ channels to
more negative potentials attribute at least in part to the inhibition of INa by sigma
receptors activation.
AP generation is determined by complex interaction of the voltage- and
time-dependent properties of primarily Na+ and K+ selective ion channels (Hille,
2001). In different types of neurons, the contribution of the generation of AP
firing by different ion channels is different. For example, in guinea-pig
sympathetic neurons (Locknar et al., 2004) and mudpuppy parasympathetic
neurons (Parsons et al., 2002; Barstow et al., 2004), the outward current which is
activated by Ca2+ -induced calcium release (CICR) at membrane voltages
approaching the threshold for AP initiation regulates AP generation, and the
disruption of CICR by thapsigargin, ryanodine and Cd2+ decreased the latency of
AP generation in these neurons. Parson et al proposed the mechanism of this
effect that when membrane depolarization approach the threshold for AP
generation, Ca2+ influx through voltage-dependent Ca2+ channels initiates CICR.
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The Ca2+ released from internal stores raises the intracellular Ca2+
concentrations in domains between the ER and the plasma membrane to levels
high enough (≥40 µM) to activate membrane outward currents that decrease the
effectiveness of the depolarizing current (Parsons et al., 2002). Also in these
neurons, big Ca2+- activated K+ channels (BK), which are at least in part
activated by CICR, regulate the generation of AP as well, and blocking the BK by
iberiotoxin or 500 µM of TEA decrease the latency of AP generation (Parsons et
al., 2002; Locknar et al., 2004). The common property of these two types of
neurons is that none of them express M-currents or express M-currents in only a
small subpopulation of cells. While in mammalian intracardiac neurons that
express M-current, CICR inhibition did not affect the latency of AP generation
(K.L. Barstow & R.L. Parson, unpublished observations; Dehaven and Cuevas,
2004). Therefore in rat ICG neurons, the initiation of AP firing is determined by
voltage-dependent Na+ channels and M-channels. Since blocking M-current,
which opposes depolarizing stimuli, would decrease the latency of AP firing, the
increased latency of AP firing by sigma receptors ligands must be through the
inhibition of voltage-gated Na+ channels. At normal resting membrane potential,
in the presence of sigma ligands, a smaller portion of Na+ channels is available
for activation by excitatory depolarization.
Sigma receptor ligands have been shown to exert neuroprotective effects
both in vivo and in vitro (Lobner and Lipton 1990; Poignet et al., 1992; Takahashi
et al., 1996; Lockhart et al., 1995; Kimura et al., 1998 Goyagi et al., 2001;). but
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the mechanisms of this effect are not well known. Disturbance in intracellular ion
homeostasis induced by ischemia is implicated in the initiation and progression of
neuronal injury. It has been proposed that the mechanism of neuronal toxicity
during oxygen/glucose deprivation is the increase of glutamate efflux into the
intracellular space by overactivating glutamate receptors, calcium channels and
sodium channels (Kimura et al., 1998). The neuroprotective effects of the Na+
channel blocker TTX have been demonstrated both in vivo and in vitro (Prenen et
al., 1998; Boening et al., 1989; Yamasaki et al., 1991; Weber and Taylor, 1994;
Xie et al., 1994). Even though there is no clear evidence shown that sigma
receptors modulate voltage-gated Na+ channels in central nervous system, in rat
hippocampus, sigma ligands have been shown to suppress CA1 neuronal activity
by increasing the threshold of action potential firing (Ishihara and Sasa, 2002).
Inhibition of voltage-gated Na+ channels may mediate this effect and these
effects on the hippocampal neurons may contribute to the neuroprotective effects
of sigma ligands.
The present data indicate that sigma ligands have inhibitory effects on
voltage-gated Na+ channels and this effect causes the threshold of AP
generation to increase, as well as the amplitude of AP overshoot to decrease. In
parasympathetic neurons, the inhibition of the AP firing in response to
depolarizing stimuli may be expected to reduce the bradycardia associated with
vagal nerve stimulation in vivo, leading to tachycardia. One of the common side
effects of local anesthetics, such as ketamine, is increasing the heart rate. It has
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been shown that ketamine inhibits Na+ but not K+ channels in brainstem
parasympathetic cardiac neurons and this action may mediate the decrease in
parasympathetic cardiac activity and increase the heart rate as seen in surgical
patients (Irnaten et al., 2002). Thus, our data suggest that the tachycardia effect
caused by sigma ligands (+)-SKF-10,047, DTG and (+)-3-[3-hydroxyphenyl]-N(1- propyl)piperidine (Wu and Martin, 1989; Lishmanov et al., 2000b) may be
mediated in part by the inhibition of voltage-gated Na+ channels in rat ICG
neurons via the activation of sigma receptors. Further, these results on
peripheral neurons have broad implications in CNS and stroke.
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CHAPTER 5
SUMMARY

The effects of sigma receptors activation on voltage-gated ion channels,
including Ca2+, K+ and Na+ channel, were investigated in neonatal rat autonomic
neurons. The results presented here provide the first evidence that sigma-1
receptor transcripts are expressed in superior cervical ganglia (SCG) and
intracardiac ganglia (ICG) neurons, which mediate sympathetic and
parasympathetic input to the heart, respectively. Furthermore, activation of
sigma-1 or sigma-2 receptors modulates voltage-gated ion channels and
decreases the excitability of these cells.
The sigma-1 receptor has been cloned in several species and these
receptors are expressed in brain and various peripheral tissues and organs
(Walker et al., 1990). By using single cell RT-PCR techniques, we found that
sigma-1 receptor transcripts are present specifically in both SCG and ICG
neurons, with only the conventional isoform expressed in these cells.
The effects of sigma ligands, (+)-pentazocine (selective sigma-1 receptor
agonist), ibogaine (selective sigma-2 receptor agonist), DTG (sigma receptor
agonist with equal affinity of sigma-1 and sigma-2) and haloperidol (sigma-2
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receptor agonist), on voltage-gated Ca2+ channel currents were studied by using
whole cell patch-clamp technique under voltage-clamp mode in SCG and ICG
neurons. Our data showed that sigma receptor agonists inhibit Ca2+ channel
currents in a dose-dependent manner and reversibly, with maximal inhibition of
over 95% of the peak current amplitude, indicating that all Ca2+ channel types
which include N-, L-, P/Q, and R-type Ca2+ channels are affected. In addition to
affecting a broad population of Ca2+ channel types, sigma ligands have
significant effects on the kinetic properties of Ca2+ channels. In the presence of
sigma ligands, the steady-state inactivation of Ca2+ channels shifted to more
negative potentials. In control cells, the inactivation curve was best fit by a onecomponent Boltzmann distribution, but by a two-component Blotzmann
distribution in the presence of sigma ligands. This observation suggests that
sigma receptors may not equally modulate steady-state inactivation in all Ca2+
channel subtypes found in these cells. Sigma receptors activation also altered
the voltage-dependence of activation of Ca2+ in a manner distinct from other
known Ca2+ channel inhibitors. In the presence of sigma receptor ligands, the
Ca2+ activation curve was shifted toward more negative potentials. In contrast,
other inhibitors of Ca2+ channels, such as muscarinic and α-adrenergic agonists,
shift the activation curve to more positive potentials (Cuevas and Admas 1997;
Xu and Admas 1993). Thus, stronger depolarizations are required in the
presence of these agents to activate the same number of Ca2+ channels. The
structure dissimilarity of sigma ligands and the lack of any significant homology
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between Ca2+ channels and the cloned sigma-1 receptor suggest that the effects
of sigma ligands are likely mediated by a sigma receptor and not a direct effect
on the Ca2+ channel. This is also approved by the observation that the sigma
receptor antagonist, metaphit that specifically acetylate sigma receptors and
block ligand binding (Bluth et al., 1989), blocked the DTG-mediated attenuation
of Ca2+ channels. The half-maximal inhibitory concentration (IC50) for
haloperidol, ibogaine, (+)-pentazocine and DTG were 6, 31, 61 and 133 µM,
respectively. The rank order potency of haloperidol > ibogaine > (+)-pentazocine
> DTG is consistent with the effects on Ca2+ channels being mediated by a
sigma-2 receptor. The primary mechanism by which other known modulators of
Ca2+ in autonomic neurons depress Ca2+ current is via the activation of pertussis
toxin-sensitive G protein (Cuevas and Adams, 1997). However, no such Gprotein appears to be implicated in the signal transduction cascade coupling
sigma receptors and Ca2+ channels in these cells, since intracellular dialysis with
GDP-β-S failed to inhibit the effects of sigma ligands. Furthermore, the inability
of cell dialysis to block the effects of sigma receptors suggests that a diffusible
cytosolic second messenger is likely not involved.
Sigma receptors have been shown to modulate K+ channels in various cell
types. Mammalian ICG neurons exhibit currents mediated by delayed outwardly
rectifying K+ channels (IK(DR)) (Xi-Moy and Dun, 1995; Hogg et al., 1999) and
express various subunits that contribute to these channels, including KCNA5 and
KCNA6 (Cuevas, unpublished observation). In neonatal rat ICG neurons, effects
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of sigma receptor activation on voltage-dependent K+ channels were studied by
whole cell patch-clamp techniques under voltage-clamp mode. Sigma receptor
activation inhibits multiple K+ channel subtypes in ICG neurons, which include
K(DR), large conductance Ca2+-activated K (BK), and M channels, with maximal
inhibition > 80%. The inhibition on IK(DR) is dose-dependent and IC50 values for
(+)-pentazocine, ibogaine and DTG are 76.4, 218 and 341 µM, respectively. The
rank order of potency of (+)-pentazocine > ibogaine > DTG suggests that the
effect is mediated by sigma-1 receptor activation. The IC50 values for the various
sigma ligands tested here are in agreement with those reported in the literature
for modulation of voltage-activated K+ channels. The inhibitory effect of Ik of DTG
is blocked by pretreatment with metaphit, an irreversible sigma receptor
antagonist, which strengthens the observation that sigma receptors mediate the
effects of DTG on IK in these cells. To determine whether sigma receptormediated inhibition of K+ channels in ICG neurons is dependent on G-protein
activation, neurons are dialyzed with pipette solution containing either 100 µM
GTP or 100 µM GDP-β-S. Intracellular application of GDP-β-S fails to block
sigma-1 receptor-mediated inhibition of IK(DR). Thus neither a diffusible cytosolic
second messenger nor a G-protein couples sigma-1 receptors to IK(DR), which is
in agreement with the direct protein-protein interaction between sigma-1
receptors and K+ channels shown by Jackson and colleagues (Lupardus et al.,
2000; Aydar et al., 2002). Application of sigma ligands depolarizes cell
membrane of ICG neurons at rest and this effect is thought through the inhibition
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of M-current which contributes to the resting membrane potential of ICG neurons
and that inhibition of this channel depolarizes the cells (Cuevas et al., 1997). In
presence of sigma ligands, the number of action potentials (AP) fired by ICG
neurons in response to depolarizing current pulses is decreased and depressed
neuroexcitability likely results from modulation of IK(DR) by sigma receptors. In
addition to decreased AP firing, sigma receptor activation also alters the AP
configuration by decreasing both the AP overshoot and afterhyperpolarization
(AHP) and by slowing both the rate of depolarization. These latter effects result in
the increase in AP duration. The inhibition of BK currents by sigma ligands
would account, at least in part, for the increase in AP duration and decrease in
AHPs
In ICG neurons, the inhibition of voltage-gated Ca2+ and K+ channels can
not explain the significant decrease in the amplitude of the first AP overshoot and
complete block of the firing at higher concentration of sigma ligands. Effects of
sigma receptor activation on voltage-gated Na+ channels were investigated in
these neurons. The voltage-activated Na+ channel in ICG neurons is TTXsensitive, with complete blockade at 300 nM TTX. Bath application of sigma
ligands inhibits INa in a reversible dose-dependent manner. Based on the fact
that the potency (IC50 values) of blocking Na+ channels is similar as Ca2+
channels inhibition by selective sigma-1 and sigma-2 receptor ligands,
(+)pentazocine (51 µM compared with 61 µM) and ibogaine (31 µM compared
with 31 µM) (Table 5.1), the inhibition of Na+ channels by sigma ligands is also
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through sigma-2 receptor activation. The fast inactivation of Na+, which was
determined by double-pulse protocol, shifts to more negative potentials in the
presence of sigma ligand, DTG. Since the fast inactivation of Na+ channel is
mainly involved in the current and the peak amplitude of INa, the shifting of the
steady-state inactivation of Na+ to more negative potential attribute at least in
part to the inhibition of INa by sigma receptors activation. One of the effects that
results from the inhibition of voltage-gated Na+ channels by sigma receptors
activation is a increase in the threshold of AP generation in response to a 400 ms
current ramp. Based on our and other group findings, we believe that in rat ICG
neurons, the initiation of AP firing in response to current ramp is determined by
voltage-gated Na+ channels and M-channels. Since blocking M-channels, which
opposes depolarizing stimuli, would decrease the threshold of AP firing, the
increase of threshold (latency) of AP firing is likely through the inhibition of Na+
channels.
The present data show that sigma-2 receptors modulate high-voltagegated Ca2+ channels in both neonatal rat SCG and ICG neurons. In rat ICG
neurons, sigma ligands have inhibitory effects on various types of K+ channels,
as well as voltage-gated Na+ channels, mediated by sigma-1 receptor and sigma2 receptor activation, respectively. The net effect of sigma receptor modulation
of ion channels in ICG neurons is decreased neuroexcitability in these neurons
suggesting that the activation of sigma receptors in ICG neurons will likely to
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attenuate parasympathetic input to the heart, and consequently, will affect
cardiovascular function.

Table 5.1 IC50 values of selective sigma-1 receptor agonist, (+)-pentazocine and
sigma-2 receptor agonist, ibogaine on voltage-gated Ca2+, K+ and Na+ channels.

K+ channel

Na+ channel

(+)-Pentazocine 61 µM

76 µM

51 µM

Ibogaine

218 µM

31 µM

Drug

Ca2+ channel

31 µM
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CONCLUSION

Since sigma receptors were first identified in the central nervous system,
they have been surrounded with a considerable amount of controversy and
confusion in their physiological functions. The distribution of these receptors
appears ubiquitous, and besides the CNS, they have been shown to be present
in numerous peripheral tissues. Furthermore, sigma receptors are found to be a
distinct pharmacological entity distinguished by their unusually promiscuous
ability to bind a wide variety of drugs and their unique distribution in subcellular
fractions. While sigma receptors have been implicated in a variety of
physiological and pathological conditions, the cellular function of these receptors
remains poorly understood.
Several studies have shown that sigma receptors may be involved in the
regulation of cardiovascular function. Cardiac performance is continuously
modulated by both sympathetic and parasympathetic branches of the autonomic
nervous system. With respect to neural control of the heart, rat superior cervical
ganglia (SCG) contain sympathetic efferent postganglionic neurons, which
innervate various regions of the heart, and intracardiac ganglia (ICG) form the
principal final common pathway for autonomic modulation of regional cardiac
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function (Armour, 1994). Investigatiing of the effects of sigma receptor activation
on these neurons will help us understand the function of these receptors in the
cardiovascular system. Results reported here using structurally dissimilar sigma
ligands show that sigma receptor activation inhibits multiple voltage-gated ion
channels in autonomic neurons. The overall effect of the blocking these channels
is an inhibition of neuroexcitability in these cells. These data indicate that
activation of sigma receptors may block signal transduction through autonomic
ganglia and onto the heart. Thus the deleterious cardiac side effects induced by
recreational drugs (e.g. PCP and cocaine) or clinical drugs (e.g. antipsychotic
and antidepressants), which have high affinity with sigma receptors, may be due
to their interaction with sigma receptors in autonomic neurons. Also the effects
of sigma receptors on these autonomic neurons suggest that sigma receptors
may mediate the cardiovascular effects of progesterone, a putative for the
endogenous sigma ligand.
The data reported here will not only serve to increase our understanding
of sigma receptors in the heart, but also on the cellular function of these
receptors in other tissues and organs. For example, both subtypes of sigma
receptors have been found highly expressed in tumor cell lines from various
human cancer tissues, and some studies demonstrate that sigma ligands
inhibited the proliferation of tumor cells in vitro (Brent and Pang, 1995; Moody et
al., 2000; Crawford and Bowen, 2002). The mechanism(s) underlying the
inhibitory effect of sigma drugs on tumor cell proliferation has not fully been
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discerned. Ion channels are expressed in several cancer cell lines and play an
important role in metastasis (Fraser et al., 2003; Wonderlin et al., 1996; Wilke et
al., 1999). The observations that sigma receptors are overexpressed in tumor
cells and modulate various voltage-gated ion channels as seen in this report
provide more evidence to support the potential of sigma ligands as anticancer
drugs. In CNS, sigma ligands have been shown to exert neuroprotective effects
both in vivo and in vitro (Lobner and Lipton 1990; Poignet et al., 1992; Takahashi
et al., 1996; Lockhart et al., 1995; Kimura et al., 1998 Goyagi et al., 2001;). but
the mechanisms of this effect are not well known. The modulations of ion
channels by sigma receptors may mediate, at least in part, the neuroprotective
effects of sigma ligands during ischemia.
The most interesting unresolved questions from the sigma receptors
research are the mechanism(s) of signal transduction. Based on the results seen
in the study of the effect of sigma-1 receptor on K+ channels, Jackson and
colleagues have elucidated a novel mechanism of cellular signal transduction. In
this model, they proposed that in response to excellular signals, sigma receptors
are capable of modulating ion channels function by interacting either with
channel proteins or some very closely associated membrane constituent (Aydar
et al., 2002). This behavior of sigma receptors can be explained by ‘three-state
allosteric’ mechanism (Leff et al., 1997). The model of protein-protein interaction
could be used to explain the results we show here. First, our data show that
neither a diffusible cytosolic second messenger nor a G-protein is involved in the
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modulations of ion channels by sigma receptor ligands. Second, some of the
sigma receptor antagonist, such as, BD1063 and BD1047, act as sigma receptor
agonist in the modulation of ion channels in autonomic neurons. This
phenomenon suggests that the cellular effects of sigma ligands depend on the
effector target. The conformational changes of sigma receptors in response to
the ligand binding can cause agonist-like effect or antagonist-like effect, which is
dependent on the effector targets that are close to sigma receptors in the
microdomains of the cell membrane.
In conclusion, our studies of the effects of sigma receptors activation on
voltage-gated ion channels in rat SCG and ICG neurons not only increase the
knowledge of sigma receptors in the heart, but also have implications for a broad
range of physiological and pathophysiological processes, such as cancer and
stroke.
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